Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-1059683	Interleukin-6 signaling	 11	0.0122503408840972	0.106510072996144	9	2	7526	9621	1.86308741026724
R-HSA-109606	Intrinsic Pathway for Apoptosis	 41	0.317335345809744	0.660348208150657	20	21	7515	9602	1.11078382183955
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	 58	0.000733786739869156	0.0196108103223855	38	20	7497	9603	1.49189758140173
R-HSA-109703	PKB-mediated events	 38	0.0053737940203628	0.063691141302213	25	13	7510	9610	1.49809660182307
R-HSA-109704	PI3K Cascade	 69	0.0405820084266566	0.191031312383645	38	31	7497	9592	1.25405883654059
R-HSA-110056	MAPK3 (ERK1) activation	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-110312	Translesion synthesis by REV1	 15	0.0651599596360025	0.255945316956402	10	5	7525	9618	1.51807122318071
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	 37	0.337327056432158	0.677975865828461	18	19	7517	9604	1.10778170340214
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	 27	0.152584149440501	0.418457570128669	15	12	7520	9611	1.26505935265059
R-HSA-110320	Translesion Synthesis by POLH	 18	0.0144331621177994	0.116404733529945	13	5	7522	9618	1.64457715844577
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	  8	0.0154976542898073	0.120704587411471	7	1	7528	9622	1.99246848042468
R-HSA-110329	Cleavage of the damaged pyrimidine 	  8	0.0154976542898073	0.120704587411471	7	1	7528	9622	1.99246848042468
R-HSA-110357	Displacement of DNA glycosylase by APEX1	  9	0.00757721462169577	0.0789697739899982	8	1	7527	9622	2.02409496424095
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	  7	0.0312840930957045	0.166822306132956	6	1	7529	9622	1.9518058583752
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	 23	0.156558000868215	0.418457570128669	13	10	7522	9613	1.2870603848706
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-111447	Activation of BAD and translocation to mitochondria 	 15	0.0651599596360025	0.255945316956402	10	5	7525	9618	1.51807122318071
R-HSA-111448	Activation of NOXA and translocation to mitochondria	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-111465	Apoptotic cleavage of cellular proteins	 32	0.818172923070628	1	12	20	7523	9603	0.853915063039151
R-HSA-111471	Apoptotic factor-mediated response	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-111885	Opioid Signalling	 77	0.0624483512716973	0.248154818610272	41	36	7494	9587	1.2124854574755
R-HSA-111931	PKA-mediated phosphorylation of CREB	 20	0.71578005443536	1	8	12	7527	9611	0.910842733908427
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-111933	Calmodulin induced events	 28	0.466065138197773	0.800629181213145	13	15	7522	9608	1.05722817328657
R-HSA-111957	Cam-PDE 1 activation	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-111996	Ca-dependent events	 30	0.449507251735669	0.787504349763132	14	16	7521	9607	1.0626498562265
R-HSA-111997	CaM pathway	 28	0.466065138197773	0.800629181213145	13	15	7522	9608	1.05722817328657
R-HSA-112040	G-protein mediated events	 45	0.528911334667114	0.861237493041779	20	25	7515	9598	1.01204748212047
R-HSA-112043	PLC beta mediated events	 44	0.596371787854456	0.925802672944902	19	25	7516	9598	0.983296133196598
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	 12	0.236071364521815	0.534520302356683	7	5	7528	9618	1.32831232028312
R-HSA-112310	Neurotransmitter Release Cycle	 46	3.51252633110377e-05	0.00341969527806746	34	12	7501	9611	1.68307896483079
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	  8	0.928935406156623	1	2	6	7533	9617	0.569276708692767
R-HSA-112382	Formation of RNA Pol II elongation complex 	 49	0.042845669616077	0.195706844630345	28	21	7507	9602	1.30120390558347
R-HSA-112387	Elongation arrest and recovery	 39	0.221072870582427	0.534520302356683	20	19	7515	9604	1.16774709475439
R-HSA-112409	RAF-independent MAPK1/3 activation	 23	0.0769820400306472	0.281746548061106	14	9	7521	9614	1.38606502986065
R-HSA-112411	MAPK1 (ERK2) activation	  9	0.043219193128198	0.195706844630345	7	2	7528	9621	1.77108309371083
R-HSA-113418	Formation of the Early Elongation Complex	 26	0.00811200895484969	0.0813086996479031	18	8	7517	9615	1.57645857791843
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	 12	0.236071364521815	0.534520302356683	7	5	7528	9618	1.32831232028312
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-113510	E2F mediated regulation of DNA replication	 28	0.200063860455279	0.502186080663988	15	13	7520	9610	1.2198786614845
R-HSA-114452	Activation of BH3-only proteins	 30	0.311113753296263	0.654395132319145	15	15	7520	9608	1.13855341738553
R-HSA-114508	Effects of PIP2 hydrolysis	 25	0.154675852577038	0.418457570128669	14	11	7521	9612	1.2751798274718
R-HSA-114516	Disinhibition of SNARE formation	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-114604	GPVI-mediated activation cascade	 48	0.973945370658943	1	15	33	7520	9590	0.711595885865959
R-HSA-1169091	Activation of NF-kappaB in B cells	 56	0.0316999099695052	0.166822306132956	32	24	7503	9599	1.30120390558347
R-HSA-1169092	Activation of RAS in B cells	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-1169408	ISG15 antiviral mechanism	 66	0.265071201856114	0.58272910988691	32	34	7503	9589	1.10405179867688
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	 66	0.265071201856114	0.58272910988691	32	34	7503	9589	1.10405179867688
R-HSA-1170546	Prolactin receptor signaling	 12	0.0976289155347392	0.32217433314042	8	4	7527	9619	1.51807122318071
R-HSA-1181150	Signaling by NODAL	 15	0.710877821951124	1	6	9	7529	9614	0.910842733908427
R-HSA-1187000	Fertilization	 11	0.925227670384916	1	3	8	7532	9615	0.621029136755746
R-HSA-1221632	Meiotic synapsis	 49	0.92730967420374	1	17	32	7518	9591	0.790016656961391
R-HSA-1222556	ROS, RNS production in phagocytes	 26	0.0537352408009065	0.2295960288766	16	10	7519	9613	1.40129651370527
R-HSA-1226099	Signaling by FGFR in disease	 55	0.0733408430076104	0.276907393405465	30	25	7505	9598	1.24205827351149
R-HSA-1227986	Signaling by ERBB2	 45	0.0101827079754208	0.0925268731366572	28	17	7507	9606	1.41686647496866
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	 10	0.887922556996002	1	3	7	7532	9616	0.683132050431321
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	 63	0.234955279560969	0.534520302356683	31	32	7504	9591	1.1204811409191
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	 55	0.118720393473002	0.356562653199804	29	26	7506	9597	1.20065633106111
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	 17	0.00669372185778721	0.0735769588077739	13	4	7522	9619	1.74131699129552
R-HSA-1236394	Signaling by ERBB4	 37	0.00823228213603127	0.0813086996479031	24	13	7511	9610	1.47704227120286
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	  7	0.98256225178826	1	1	6	7534	9617	0.325300976395867
R-HSA-1236974	ER-Phagosome pathway	 69	0.478836976113134	0.817863155942609	31	38	7504	9585	1.02304799823048
R-HSA-1236975	Antigen processing-Cross presentation	 81	0.677572603201883	0.986256998599357	34	47	7501	9576	0.955822622002671
R-HSA-1236977	Endosomal/Vacuolar pathway	  9	0.955859164923054	1	2	7	7533	9616	0.506023741060237
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	 38	0.275428951631903	0.59778608451319	19	19	7516	9604	1.13855341738553
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-1237112	Methionine salvage pathway	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	  5	1	1	0	5	7535	9618	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	 19	0.0726693044916316	0.275900451315025	12	7	7523	9616	1.43817273775015
R-HSA-1250342	PI3K events in ERBB4 signaling	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-1250347	SHC1 events in ERBB4 signaling	 12	0.0976289155347392	0.32217433314042	8	4	7527	9619	1.51807122318071
R-HSA-1251985	Nuclear signaling by ERBB4	 21	0.0751401417305087	0.280647041264833	13	8	7522	9615	1.40963756438209
R-HSA-1253288	Downregulation of ERBB4 signaling	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-1266695	Interleukin-7 signaling	 15	0.513696151536041	0.849718270077214	7	8	7528	9615	1.0626498562265
R-HSA-1268020	Mitochondrial protein import	 52	0.000196463893216458	0.0083681339516885	36	16	7499	9607	1.57645857791843
R-HSA-1295596	Spry regulation of FGF signaling	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-1296041	Activation of G protein gated Potassium channels	 22	0.0499123510164293	0.220163541862114	14	8	7521	9615	1.44906798576341
R-HSA-1296052	Ca2+ activated K+ channels	  8	0.928935406156623	1	2	6	7533	9617	0.569276708692767
R-HSA-1296059	G protein gated Potassium channels	 22	0.0499123510164293	0.220163541862114	14	8	7521	9615	1.44906798576341
R-HSA-1296065	Inwardly rectifying K+ channels	 26	0.111836572080748	0.341462890835091	15	11	7520	9612	1.31371548159869
R-HSA-1296071	Potassium Channels	 87	0.788398457558349	1	35	52	7500	9571	0.916077462264223
R-HSA-1296072	Voltage gated Potassium channels	 39	0.880008475195838	1	14	25	7521	9598	0.817422966328076
R-HSA-1296346	Tandem pore domain potassium channels	 10	0.972843316904817	1	2	8	7533	9615	0.455421366954214
R-HSA-1306955	GRB7 events in ERBB2 signaling	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	 12	0.029911718062633	0.166406823344362	9	3	7526	9620	1.7078301260783
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-1368082	RORA activates gene expression	 27	0.0362017430938798	0.180083853419555	17	10	7518	9613	1.43373393300401
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	 45	0.130660049734355	0.37891414422963	24	21	7511	9602	1.21445697854457
R-HSA-1369062	ABC transporters in lipid homeostasis	 15	0.315178550035463	0.657868857118432	8	7	7527	9616	1.21445697854457
R-HSA-139853	Elevation of cytosolic Ca2+ levels	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-139915	Activation of PUMA and translocation to mitochondria	  9	0.955859164923054	1	2	7	7533	9616	0.506023741060237
R-HSA-140342	Apoptosis induced DNA fragmentation	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-140534	Ligand-dependent caspase activation	 16	0.991676465832436	1	3	13	7532	9610	0.426957531519575
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	 16	0.900431366192639	1	5	11	7530	9612	0.711595885865959
R-HSA-140875	Common Pathway of Fibrin Clot Formation	 18	0.984949869969325	1	4	14	7531	9609	0.506023741060237
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	 30	0.983760597596667	1	8	22	7527	9601	0.607228489272285
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	 17	0.069411688187522	0.268773099430661	11	6	7524	9617	1.47342206955775
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	 17	0.069411688187522	0.268773099430661	11	6	7524	9617	1.47342206955775
R-HSA-1433559	Regulation of KIT signaling	 15	0.710877821951124	1	6	9	7529	9614	0.910842733908427
R-HSA-1433617	Regulation of signaling by NODAL	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-1442490	Collagen degradation	 50	0.899221149768399	1	18	32	7517	9591	0.819758460517585
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	 66	0.000402849487486117	0.0130734250343709	43	23	7492	9600	1.48356960447206
R-HSA-1461957	Beta defensins	  5	1	1	0	5	7535	9618	0
R-HSA-1461973	Defensins	  8	0.990223229735637	1	1	7	7534	9616	0.284638354346384
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	 12	0.442401915734987	0.779061771507477	6	6	7529	9617	1.13855341738553
R-HSA-1474165	Reproduction	 11	0.925227670384916	1	3	8	7532	9615	0.621029136755746
R-HSA-1474290	Collagen formation	 75	0.787942126060986	1	30	45	7505	9578	0.910842733908427
R-HSA-1475029	Reversible hydration of carbon dioxide	 11	0.925227670384916	1	3	8	7532	9615	0.621029136755746
R-HSA-1480926	O2/CO2 exchange in erythrocytes	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-1482788	Acyl chain remodelling of PC	 20	0.71578005443536	1	8	12	7527	9611	0.910842733908427
R-HSA-1482798	Acyl chain remodeling of CL	  6	0.237586605308932	0.534520302356683	4	2	7531	9621	1.51807122318071
R-HSA-1482801	Acyl chain remodelling of PS	 16	0.900431366192639	1	5	11	7530	9612	0.711595885865959
R-HSA-1482839	Acyl chain remodelling of PE	 22	0.823077583679908	1	8	14	7527	9609	0.828038849007661
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-1482922	Acyl chain remodelling of PI	 13	0.747445650914158	1	5	8	7530	9615	0.875810321065796
R-HSA-1482925	Acyl chain remodelling of PG	 14	0.811579260430306	1	5	9	7530	9614	0.813252440989667
R-HSA-1483115	Hydrolysis of LPC	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-1483148	Synthesis of PG	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-1483166	Synthesis of PA	 28	0.200063860455279	0.502186080663988	15	13	7520	9610	1.2198786614845
R-HSA-1483191	Synthesis of PC	 24	0.344140107026914	0.686768617683286	12	12	7523	9611	1.13855341738553
R-HSA-1483213	Synthesis of PE	 12	0.236071364521815	0.534520302356683	7	5	7528	9618	1.32831232028312
R-HSA-1483226	Synthesis of PI	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-1483249	Inositol phosphate metabolism	 45	0.20467968542061	0.510015377016987	23	22	7512	9601	1.16385460443855
R-HSA-1483255	PI Metabolism	 72	0.12295746176555	0.362238594236878	37	35	7498	9588	1.1701799012018
R-HSA-1489509	DAG and IP3 signaling	 34	0.292298871477691	0.624456679975067	17	17	7518	9606	1.13855341738553
R-HSA-1500620	Meiosis	 69	0.878884448961635	1	26	43	7509	9580	0.858040256580403
R-HSA-1502540	Signaling by Activin	 12	0.442401915734987	0.779061771507477	6	6	7529	9617	1.13855341738553
R-HSA-1538133	G0 and Early G1	 22	0.823077583679908	1	8	14	7527	9609	0.828038849007661
R-HSA-156580	Phase II conjugation	 62	0.470135516688295	0.804008418125654	28	34	7507	9589	1.02837082860629
R-HSA-156581	Methylation	 12	0.442401915734987	0.779061771507477	6	6	7529	9617	1.13855341738553
R-HSA-156584	Cytosolic sulfonation of small molecules	 14	0.811579260430306	1	5	9	7530	9614	0.813252440989667
R-HSA-156588	Glucuronidation	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-156590	Glutathione conjugation	 26	0.483869864954987	0.822337438820009	12	14	7523	9609	1.05097238527895
R-HSA-1566948	Elastic fibre formation	 38	0.999769786345892	1	7	31	7528	9592	0.41946704851046
R-HSA-1566977	Fibronectin matrix formation	  6	0.968899630100056	1	1	5	7534	9618	0.379517805795178
R-HSA-156711	Polo-like kinase mediated events	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	 65	0.502464167842316	0.840368102866631	29	36	7506	9587	1.01593997243632
R-HSA-156842	Eukaryotic Translation Elongation	 48	0.449024715323926	0.787504349763132	22	26	7513	9597	1.04367396593674
R-HSA-156902	Peptide chain elongation	 46	0.462247177368502	0.800629181213145	21	25	7514	9598	1.03954877239549
R-HSA-157579	Telomere Maintenance	 56	0.986700638474251	1	17	39	7518	9584	0.691264574841217
R-HSA-157858	Gap junction trafficking and regulation	 39	0.327067228628906	0.671374446718672	19	20	7516	9603	1.10935974001667
R-HSA-15869	Metabolism of nucleotides	 87	0.559053136381497	0.880912629928301	38	49	7497	9574	0.994598387601156
R-HSA-1592230	Mitochondrial biogenesis	 53	0.000354332095735458	0.0125109222973526	36	17	7499	9606	1.54671407644827
R-HSA-159227	Transport of the SLBP independent Mature mRNA	 31	0.0388332266172899	0.188361878574257	19	12	7516	9611	1.39564612453711
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	 32	0.0264323724403454	0.16012143838307	20	12	7515	9611	1.42319177173192
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	 38	0.0290119642964595	0.166406823344362	23	15	7512	9608	1.37824887367723
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	 39	0.0201001981282549	0.138962861743972	24	15	7511	9608	1.40129651370527
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	 62	0.000341483006103233	0.0125109222973526	41	21	7494	9602	1.50582871331635
R-HSA-1592389	Activation of Matrix Metalloproteinases	 27	0.999961154381876	1	3	24	7532	9599	0.253011870530119
R-HSA-159418	Recycling of bile acids and salts	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-159740	Gamma-carboxylation of protein precursors	  8	0.928935406156623	1	2	6	7533	9617	0.569276708692767
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	  7	0.98256225178826	1	1	6	7534	9617	0.325300976395867
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	  8	0.990223229735637	1	1	7	7534	9616	0.284638354346384
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	  9	0.955859164923054	1	2	7	7533	9616	0.506023741060237
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	 23	0.863393602256841	1	8	15	7527	9608	0.792037159920372
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-1614558	Degradation of cysteine and homocysteine	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-1614635	Sulfur amino acid metabolism	 21	0.158148877061764	0.418457570128669	12	9	7523	9614	1.30120390558347
R-HSA-162588	Budding and maturation of HIV virion	 22	0.214031188888199	0.528486431983	12	10	7523	9613	1.24205827351149
R-HSA-162592	Integration of provirus	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-162594	Early Phase of HIV Life Cycle	 13	0.326673412817859	0.671374446718672	7	6	7528	9617	1.22613444949211
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	 13	0.747445650914158	1	5	8	7530	9615	0.875810321065796
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	 16	0.40235351964967	0.726368009645695	8	8	7527	9615	1.13855341738553
R-HSA-162791	Attachment of GPI anchor to uPAR	  6	0.0621040375419129	0.247508196402419	5	1	7530	9622	1.89758902897589
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	 74	0.758283067043966	1	30	44	7505	9579	0.923151419501784
R-HSA-163210	Formation of ATP by chemiosmotic coupling	 14	0.00165388523296786	0.031308966285211	12	2	7523	9621	1.9518058583752
R-HSA-1632852	Macroautophagy	 63	0.00636322255599416	0.0729239587181435	38	25	7497	9598	1.37349301144922
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-163359	Glucagon signaling in metabolic regulation	 29	0.384923619130613	0.705228057906781	14	15	7521	9608	1.09929295471707
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	 17	0.977254879880017	1	4	13	7531	9610	0.535789843475545
R-HSA-163615	PKA activation	 19	0.802016631441832	1	7	12	7528	9611	0.83893409702092
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-163765	ChREBP activates metabolic gene expression	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	  7	0.139153898657434	0.395964016430236	5	2	7530	9621	1.62650488197933
R-HSA-1638074	Keratan sulfate/keratin metabolism	 31	0.933792227169568	1	10	21	7525	9602	0.734550591861635
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	 52	0.643726132423328	0.974887464992217	22	30	7513	9593	0.963391353172375
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	 32	0.898540591483791	1	11	21	7524	9602	0.782755474452555
R-HSA-1643713	Signaling by EGFR in Cancer	 17	0.00669372185778721	0.0735769588077739	13	4	7522	9619	1.74131699129552
R-HSA-164378	PKA activation in glucagon signalling	 17	0.831347184228978	1	6	11	7529	9612	0.803684765213318
R-HSA-164843	2-LTR circle formation	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	 18	0.109160004132176	0.341462890835091	11	7	7524	9616	1.39156528791565
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-164944	Nef and signal transduction	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	 24	0.0520301713650008	0.226078502371331	15	9	7520	9614	1.42319177173192
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	 33	0.0398288018001369	0.190440489911803	20	13	7515	9610	1.3800647483461
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	 56	0.507764331837534	0.846066973465231	25	31	7510	9592	1.01656555123708
R-HSA-165159	mTOR signalling	 37	0.00823228213603127	0.0813086996479031	24	13	7511	9610	1.47704227120286
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	 54	3.96459086470355e-07	0.000180124578286365	42	12	7493	9611	1.77108309371083
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	 46	0.462247177368502	0.800629181213145	21	25	7514	9598	1.03954877239549
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	 15	0.15976668396887	0.418457570128669	9	6	7526	9617	1.36626410086264
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 14	0.232292221466613	0.534520302356683	8	6	7527	9617	1.30120390558347
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	 88	0.202935847910238	0.507525799452577	43	45	7492	9578	1.11267720335404
R-HSA-1660661	Sphingolipid de novo biosynthesis	 40	0.267609093205088	0.58736102099603	20	20	7515	9603	1.13855341738553
R-HSA-1660662	Glycosphingolipid metabolism	 38	0.393035350752387	0.713325143908794	18	20	7517	9603	1.07862955331261
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade 	 92	0.0280825603239699	0.164985041903323	50	42	7485	9581	1.23755806237558
R-HSA-166208	mTORC1-mediated signalling	 21	0.158148877061764	0.418457570128669	12	9	7523	9614	1.30120390558347
R-HSA-1663150	The activation of arylsulfatases	 10	0.972843316904817	1	2	8	7533	9615	0.455421366954214
R-HSA-166658	Complement cascade	 33	0.999906671279957	1	5	28	7530	9595	0.345016187086526
R-HSA-166663	Initial triggering of complement	 18	1	1	0	18	7535	9605	0
R-HSA-166665	Terminal pathway of complement	  6	0.968899630100056	1	1	5	7534	9618	0.379517805795178
R-HSA-166786	Creation of C4 and C2 activators	 11	1	1	0	11	7535	9612	0
R-HSA-167021	PLC-gamma1 signalling	 36	0.40590349690703	0.731807495085028	17	19	7518	9604	1.075300449753
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	 37	0.00823228213603127	0.0813086996479031	24	13	7511	9610	1.47704227120286
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	 26	0.00811200895484969	0.0813086996479031	18	8	7517	9615	1.57645857791843
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	 22	0.00153539440008474	0.0294752474269789	17	5	7518	9618	1.75958255414128
R-HSA-167161	HIV Transcription Initiation	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-167169	HIV Transcription Elongation	 35	0.00764784311568582	0.0789697739899982	23	12	7512	9611	1.49638449142099
R-HSA-167172	Transcription of the HIV genome	 60	0.0171759191274252	0.125191324976901	35	25	7500	9598	1.32831232028312
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	 35	0.00764784311568582	0.0789697739899982	23	12	7512	9611	1.49638449142099
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	 25	0.078316573265455	0.281746548061106	15	10	7520	9613	1.36626410086264
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	 18	0.109160004132176	0.341462890835091	11	7	7524	9616	1.39156528791565
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	 25	0.078316573265455	0.281746548061106	15	10	7520	9613	1.36626410086264
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	 35	0.00764784311568582	0.0789697739899982	23	12	7512	9611	1.49638449142099
R-HSA-167287	HIV elongation arrest and recovery	 27	0.0792385101929455	0.281746548061106	16	11	7519	9612	1.3493966428273
R-HSA-167290	Pausing and recovery of HIV elongation	 27	0.0792385101929455	0.281746548061106	16	11	7519	9612	1.3493966428273
R-HSA-167590	Nef Mediated CD4 Down-regulation	  9	0.043219193128198	0.195706844630345	7	2	7528	9621	1.77108309371083
R-HSA-1679131	Trafficking and processing of endosomal TLR	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	 90	0.0451788579061398	0.201897650249405	48	42	7487	9581	1.21445697854457
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	 79	0.038516617912818	0.188165412957602	43	36	7492	9587	1.23943789740704
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	 92	0.0280825603239699	0.164985041903323	50	42	7485	9581	1.23755806237558
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	 79	0.038516617912818	0.188165412957602	43	36	7492	9587	1.23943789740704
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	 89	0.231759351949506	0.534520302356683	43	46	7492	9577	1.10017521230512
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	 86	0.0717042131468488	0.275900451315025	45	41	7490	9582	1.19150939028719
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	 88	0.202935847910238	0.507525799452577	43	45	7492	9578	1.11267720335404
R-HSA-168253	Host Interactions with Influenza Factors	 39	0.0418226281632535	0.195220007488063	23	16	7512	9607	1.34290915896755
R-HSA-168255	Influenza Life Cycle	 96	0.00307364684062857	0.048153800503181	56	40	7479	9583	1.32831232028312
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	 30	0.0100457154330467	0.0918946988942463	20	10	7515	9613	1.51807122318071
R-HSA-168273	Influenza Viral RNA Transcription and Replication	 87	0.0131894296560523	0.109617028178044	49	38	7486	9585	1.28250844716991
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	 31	0.0388332266172899	0.188361878574257	19	12	7516	9611	1.39564612453711
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	 37	0.0194007383268939	0.137725033018523	23	14	7512	9609	1.41549884323607
R-HSA-168325	Viral Messenger RNA Synthesis	 39	0.00346756981242385	0.0511746481943655	26	13	7509	9610	1.51807122318071
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	 30	0.0252889371093603	0.153878666428831	19	11	7516	9612	1.44216766202168
R-HSA-168638	NOD1/2 Signaling Pathway	 32	0.301436262292754	0.638969868592572	16	16	7519	9607	1.13855341738553
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	 47	0.0768208729420024	0.281746548061106	26	21	7509	9602	1.25967612136272
R-HSA-168799	Neurotoxicity of clostridium toxins	 10	0.00366572103319282	0.0511746481943655	9	1	7526	9622	2.04939615129396
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	 66	0.545854416271612	0.867804049431875	29	37	7506	9586	1.00054694255092
R-HSA-169911	Regulation of Apoptosis	 43	0.0782690076648837	0.281746548061106	24	19	7511	9604	1.27094334963967
R-HSA-170660	Adenylate cyclase activating pathway	 10	0.972843316904817	1	2	8	7533	9615	0.455421366954214
R-HSA-170670	Adenylate cyclase inhibitory pathway	 13	0.967997587249324	1	3	10	7532	9613	0.525486192639477
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	 30	0.0561505295919752	0.23548668256573	18	12	7517	9611	1.36626410086264
R-HSA-170834	Signaling by TGF-beta Receptor Complex	 69	0.383820570906169	0.705228057906781	32	37	7503	9586	1.0560495465605
R-HSA-171007	p38MAPK events	 13	0.747445650914158	1	5	8	7530	9615	0.875810321065796
R-HSA-171052	LDL-mediated lipid transport	 19	0.0726693044916316	0.275900451315025	12	7	7523	9616	1.43817273775015
R-HSA-171306	Packaging Of Telomere Ends	 28	0.999122963901317	1	5	23	7530	9600	0.406626220494834
R-HSA-171319	Telomere Extension By Telomerase	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-173623	Classical antibody-mediated complement activation	  8	1	1	0	8	7535	9615	0
R-HSA-173736	Alternative complement activation	  5	1	1	0	5	7535	9618	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	 20	0.110715314015332	0.341462890835091	12	8	7523	9615	1.36626410086264
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	 53	0.0229981864315893	0.146506213373903	31	22	7504	9601	1.33189267694157
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	 44	0.102349324950043	0.332940644169233	24	20	7511	9603	1.24205827351149
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	 72	0.0812871327141308	0.284088107408616	38	34	7497	9589	1.20180638501806
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	 55	0.0425841174723466	0.195706844630345	31	24	7504	9599	1.28346021596187
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	 60	0.0550095856724249	0.233576527325592	33	27	7502	9596	1.25240875912409
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	 59	0.0421708758831735	0.195706844630345	33	26	7502	9597	1.27363602622789
R-HSA-174362	Transport and synthesis of PAPS	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-174403	Glutathione synthesis and recycling	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-174411	Polymerase switching on the C-strand of the telomere	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-174414	Processive synthesis on the C-strand of the telomere	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	 22	0.524025508597474	0.861237493041779	10	12	7525	9611	1.03504856125958
R-HSA-174430	Telomere C-strand synthesis initiation	  7	1	1	0	7	7535	9616	0
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-174490	Membrane binding and targetting of GAG proteins	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-174577	Activation of C3 and C5	  5	1	1	0	5	7535	9618	0
R-HSA-174800	Chylomicron-mediated lipid transport	 19	0.990126613943758	1	4	15	7531	9608	0.479390912583383
R-HSA-174824	Lipoprotein metabolism	 58	0.494783365097715	0.834323171962897	26	32	7509	9591	1.02077202938013
R-HSA-175474	Assembly Of The HIV Virion	 12	0.442401915734987	0.779061771507477	6	6	7529	9617	1.13855341738553
R-HSA-176033	Interactions of Vpr with host cellular proteins	 34	0.0117199359719749	0.103729043700012	22	12	7513	9611	1.47342206955775
R-HSA-176187	Activation of ATR in response to replication stress	 27	0.00495781067942045	0.0603347853218756	19	8	7516	9615	1.60240851335742
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	 17	0.0243278765164166	0.148694599515138	12	5	7523	9618	1.60736953042664
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	 66	0.0532143063414819	0.228085218690062	36	30	7499	9593	1.24205827351149
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	 62	0.0886770725159251	0.303222076171709	33	29	7502	9594	1.2120084765717
R-HSA-176412	Phosphorylation of the APC/C	 17	0.159953333849623	0.418457570128669	10	7	7525	9616	1.33947460868886
R-HSA-176417	Phosphorylation of Emi1	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	 63	0.109816444055465	0.341462890835091	33	30	7502	9593	1.19277024678485
R-HSA-176974	Unwinding of DNA	 11	0.788442254625565	1	4	7	7531	9616	0.828038849007661
R-HSA-177243	Interactions of Rev with host cellular proteins	 35	0.0406449600816266	0.191031312383645	21	14	7514	9609	1.36626410086264
R-HSA-177504	Retrograde neurotrophin signalling	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	 48	0.449024715323926	0.787504349763132	22	26	7513	9597	1.04367396593674
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	 21	0.0751401417305087	0.280647041264833	13	8	7522	9615	1.40963756438209
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	 60	0.0550095856724249	0.233576527325592	33	27	7502	9596	1.25240875912409
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	 67	0.303125857445366	0.641553639282661	32	35	7503	9588	1.087573413622
R-HSA-180024	DARPP-32 events	 26	0.0224875675754014	0.146506213373903	17	9	7518	9614	1.48887754581185
R-HSA-180534	Vpu mediated degradation of CD4	 42	0.170641593340054	0.441336796437371	22	20	7513	9603	1.19277024678485
R-HSA-180585	Vif-mediated degradation of APOBEC3G	 44	0.102349324950043	0.332940644169233	24	20	7511	9603	1.24205827351149
R-HSA-180746	Nuclear import of Rev protein	 32	0.056957551952824	0.238138476416255	19	13	7516	9610	1.35203218314532
R-HSA-180786	Extension of Telomeres	 28	0.616183150302867	0.942601160339851	12	16	7523	9607	0.975902929187601
R-HSA-180910	Vpr-mediated nuclear import of PICs	 31	0.0167346489990891	0.123606453088308	20	11	7515	9612	1.46910118372327
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	 19	0.907721351173715	1	6	13	7529	9610	0.719086368875074
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	 16	4.07291190725486e-05	0.00370091928639225	15	1	7520	9622	2.13478765759788
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	 18	0.00371701406547482	0.0511746481943655	14	4	7521	9619	1.77108309371083
R-HSA-181431	Acetylcholine Binding And Downstream Events	  8	1	1	0	8	7535	9615	0
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	 89	0.231759351949506	0.534520302356683	43	46	7492	9577	1.10017521230512
R-HSA-182218	Nef Mediated CD8 Down-regulation	  6	0.00716497215619606	0.0768965121960254	6	0	7529	9623	2.27710683477107
R-HSA-182971	EGFR downregulation	 23	0.00347737407567639	0.0511746481943655	17	6	7518	9617	1.68307896483079
R-HSA-1834941	STING mediated induction of host immune responses	 14	0.421054604169104	0.754135907335728	7	7	7528	9616	1.13855341738553
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	 61	0.111983794719945	0.341462890835091	32	29	7503	9594	1.19454784774876
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	 17	0.0243278765164166	0.148694599515138	12	5	7523	9618	1.60736953042664
R-HSA-1839122	Signaling by activated point mutants of FGFR1	 10	0.996927117940809	1	1	9	7534	9614	0.227710683477107
R-HSA-1839124	FGFR1 mutant receptor activation	 29	0.531992622439841	0.861237493041779	13	16	7522	9607	1.02077202938013
R-HSA-1839126	FGFR2 mutant receptor activation	 26	0.774521160171455	1	10	16	7525	9607	0.875810321065796
R-HSA-1839130	Signaling by activated point mutants of FGFR3	 10	0.996927117940809	1	1	9	7534	9614	0.227710683477107
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	 27	0.551846859400684	0.870563969170291	12	15	7523	9608	1.01204748212047
R-HSA-186712	Regulation of beta-cell development	 23	0.976223943923981	1	6	17	7529	9606	0.594027869940279
R-HSA-187015	Activation of TRKA receptors	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	 50	0.156048056221341	0.418457570128669	26	24	7509	9599	1.18409555408096
R-HSA-189200	Hexose transport	 46	0.347912184281863	0.689762302653353	22	24	7513	9599	1.08905109489051
R-HSA-189445	Metabolism of porphyrins	 15	0.0651599596360025	0.255945316956402	10	5	7525	9618	1.51807122318071
R-HSA-189451	Heme biosynthesis	 11	0.0524841172200018	0.226078502371331	8	3	7527	9620	1.65607769801532
R-HSA-190236	Signaling by FGFR	 75	0.0233249070448547	0.146506213373903	42	33	7493	9590	1.2751798274718
R-HSA-190239	FGFR3 ligand binding and activation	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-190241	FGFR2 ligand binding and activation	 15	0.997829761989255	1	2	13	7533	9610	0.303614244636142
R-HSA-190242	FGFR1 ligand binding and activation	 14	0.999696604853008	1	1	13	7534	9610	0.162650488197933
R-HSA-190322	FGFR4 ligand binding and activation	 10	1	1	0	10	7535	9613	0
R-HSA-190370	FGFR1b ligand binding and activation	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-190371	FGFR3b ligand binding and activation	  6	0.968899630100056	1	1	5	7534	9618	0.379517805795178
R-HSA-190372	FGFR3c ligand binding and activation	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-190373	FGFR1c ligand binding and activation	 11	0.998277372566188	1	1	10	7534	9613	0.207009712251915
R-HSA-190375	FGFR2c ligand binding and activation	 11	0.998277372566188	1	1	10	7534	9613	0.207009712251915
R-HSA-190377	FGFR2b ligand binding and activation	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-190828	Gap junction trafficking	 37	0.226981632412461	0.534520302356683	19	18	7516	9605	1.16932513136893
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	 12	0.442401915734987	0.779061771507477	6	6	7529	9617	1.13855341738553
R-HSA-190861	Gap junction assembly	 26	0.876543454389755	1	9	17	7526	9606	0.788229288959216
R-HSA-190872	Transport of connexons to the plasma membrane	 13	0.541597775378239	0.86541356136054	6	7	7529	9616	1.05097238527895
R-HSA-190873	Gap junction degradation	 12	0.000836990248006496	0.0211262538524603	11	1	7524	9622	2.08734793187348
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-1912408	Pre-NOTCH Transcription and Translation	 29	0.0376335741024064	0.185849860512971	18	11	7517	9612	1.4133766560648
R-HSA-1912420	Pre-NOTCH Processing in Golgi	 18	0.385675219632249	0.705228057906781	9	9	7526	9614	1.13855341738553
R-HSA-1912422	Pre-NOTCH Expression and Processing	 45	0.0427017852580353	0.195706844630345	26	19	7509	9604	1.31566172675662
R-HSA-191273	Cholesterol biosynthesis	 23	0.032510408078718	0.169128573325544	15	8	7520	9615	1.4850696748507
R-HSA-191859	snRNP Assembly	 47	0.0768208729420024	0.281746548061106	26	21	7509	9602	1.25967612136272
R-HSA-192105	Synthesis of bile acids and bile salts	 27	0.398898621897867	0.723003752189884	13	14	7522	9609	1.09638477229718
R-HSA-192456	Digestion of dietary lipid	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-192823	Viral mRNA Translation	 46	0.462247177368502	0.800629181213145	21	25	7514	9598	1.03954877239549
R-HSA-193048	Androgen biosynthesis	  9	0.353145803414631	0.693570216216343	5	4	7530	9619	1.26505935265059
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	 17	0.678006461986498	0.986256998599357	7	10	7528	9613	0.937632226082205
R-HSA-193634	Axonal growth inhibition (RHOA activation)	  9	0.353145803414631	0.693570216216343	5	4	7530	9619	1.26505935265059
R-HSA-193639	p75NTR signals via NF-kB	 15	0.710877821951124	1	6	9	7529	9614	0.910842733908427
R-HSA-193648	NRAGE signals death through JNK	 51	0.0751549303460486	0.280647041264833	28	23	7507	9600	1.25017630144294
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	  6	0.968899630100056	1	1	5	7534	9618	0.379517805795178
R-HSA-193692	Regulated proteolysis of p75NTR	  9	0.353145803414631	0.693570216216343	5	4	7530	9619	1.26505935265059
R-HSA-193697	p75NTR regulates axonogenesis	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-193704	p75 NTR receptor-mediated signalling	 85	0.0371589018932305	0.184173030110811	46	39	7489	9584	1.23231663999375
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	  9	0.99451873783721	1	1	8	7534	9615	0.253011870530119
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-194002	Glucocorticoid biosynthesis	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-194068	Bile acid and bile salt metabolism	 32	0.301436262292754	0.638969868592572	16	16	7519	9607	1.13855341738553
R-HSA-194223	HDL-mediated lipid transport	 16	0.777226929319867	1	6	10	7529	9613	0.853915063039151
R-HSA-194313	VEGF ligand-receptor interactions	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-194441	Metabolism of non-coding RNA	 47	0.0768208729420024	0.281746548061106	26	21	7509	9602	1.25967612136272
R-HSA-195253	Degradation of beta-catenin by the destruction complex	 74	0.00967661490039248	0.0903371651317462	43	31	7492	9592	1.32318370128589
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-196025	Formation of annular gap junctions	 11	0.00175802773299185	0.0319742557293318	10	1	7525	9622	2.07009712251915
R-HSA-196071	Metabolism of steroid hormones	 23	0.747485048848158	1	9	14	7526	9609	0.891041804910418
R-HSA-196108	Pregnenolone biosynthesis	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-196299	Beta-catenin phosphorylation cascade	 17	0.00669372185778721	0.0735769588077739	13	4	7522	9619	1.74131699129552
R-HSA-1963640	GRB2 events in ERBB2 signaling	 13	0.0596391965049837	0.24121134966259	9	4	7526	9619	1.57645857791843
R-HSA-1963642	PI3K events in ERBB2 signaling	 13	0.0596391965049837	0.24121134966259	9	4	7526	9619	1.57645857791843
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	 18	0.385675219632249	0.705228057906781	9	9	7526	9614	1.13855341738553
R-HSA-196757	Metabolism of folate and pterines	 12	0.0976289155347392	0.32217433314042	8	4	7527	9619	1.51807122318071
R-HSA-196780	Biotin transport and metabolism	 11	0.155313269279354	0.418457570128669	7	4	7528	9619	1.44906798576341
R-HSA-196783	Coenzyme A biosynthesis	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-196807	Nicotinate metabolism	 27	0.698330777455614	1	11	16	7524	9607	0.927710191943769
R-HSA-196836	Vitamin C (ascorbate) metabolism	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	 26	0.483869864954987	0.822337438820009	12	14	7523	9609	1.05097238527895
R-HSA-197264	Nicotinamide salvaging	 16	0.965951718028444	1	4	12	7531	9611	0.569276708692767
R-HSA-1980143	Signaling by NOTCH1	 68	0.0525802533027968	0.226078502371331	37	31	7498	9592	1.2390140130372
R-HSA-1980145	Signaling by NOTCH2	 28	0.0239792226201717	0.148562183778609	18	10	7517	9613	1.4638543937814
R-HSA-1980148	Signaling by NOTCH3	 10	0.0232231889757075	0.146506213373903	8	2	7527	9621	1.82168546781685
R-HSA-1980150	Signaling by NOTCH4	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-198323	AKT phosphorylates targets in the cytosol	 13	0.158412465982348	0.418457570128669	8	5	7527	9618	1.40129651370527
R-HSA-198693	AKT phosphorylates targets in the nucleus	  9	0.353145803414631	0.693570216216343	5	4	7530	9619	1.26505935265059
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	 25	0.0130881638619638	0.109442744440838	17	8	7518	9615	1.54843264764433
R-HSA-198753	ERK/MAPK targets	 22	0.0188983422612944	0.134860945037405	15	7	7520	9616	1.55257284188936
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	 88	0.99999999999999	1	7	81	7528	9542	0.181133498220426
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	 15	0.0651599596360025	0.255945316956402	10	5	7525	9618	1.51807122318071
R-HSA-199418	Negative regulation of the PI3K/AKT network	 81	0.50458197566905	0.841793430644939	36	45	7499	9578	1.01204748212047
R-HSA-199920	CREB phosphorylation	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-199992	trans-Golgi Network Vesicle Budding	 64	5.35944006147428e-06	0.000831940432382631	46	18	7489	9605	1.63667053749171
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-201451	Signaling by BMP	 23	0.156558000868215	0.418457570128669	13	10	7522	9613	1.2870603848706
R-HSA-201688	WNT mediated activation of DVL	  7	0.98256225178826	1	1	6	7534	9617	0.325300976395867
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	 56	0.993813964419636	1	16	40	7519	9583	0.650601952791734
R-HSA-202040	G-protein activation	 22	0.356826686917845	0.695786515406328	11	11	7524	9612	1.13855341738553
R-HSA-202131	Metabolism of nitric oxide	 22	0.356826686917845	0.695786515406328	11	11	7524	9612	1.13855341738553
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	 51	0.864934148445936	1	19	32	7516	9591	0.84833391883628
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	 12	0.989950553014577	1	2	10	7533	9613	0.379517805795178
R-HSA-2022854	Keratan sulfate biosynthesis	 25	0.841228044852651	1	9	16	7526	9607	0.819758460517585
R-HSA-2022857	Keratan sulfate degradation	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-2022870	Chondroitin sulfate biosynthesis	 19	0.294678640283665	0.628555534752168	10	9	7525	9614	1.19847728145846
R-HSA-2022923	Dermatan sulfate biosynthesis	 11	0.574160276360291	0.898485024889869	5	6	7530	9617	1.03504856125958
R-HSA-2022928	HS-GAG biosynthesis	 28	0.857035647868598	1	10	18	7525	9605	0.813252440989667
R-HSA-202403	TCR signaling	 91	0.0556953476127094	0.235024021040628	48	43	7487	9580	1.20111129746166
R-HSA-2024096	HS-GAG degradation	 22	0.823077583679908	1	8	14	7527	9609	0.828038849007661
R-HSA-2024101	CS/DS degradation	 13	0.326673412817859	0.671374446718672	7	6	7528	9617	1.22613444949211
R-HSA-202424	Downstream TCR signaling	 75	0.0393808072907356	0.190340568571889	41	34	7494	9589	1.24481840300818
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	 12	0.989950553014577	1	2	10	7533	9613	0.379517805795178
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	 10	0.972843316904817	1	2	8	7533	9615	0.455421366954214
R-HSA-202433	Generation of second messenger molecules	 22	0.688271289905648	0.995874488472821	9	13	7526	9610	0.931543705133619
R-HSA-202670	ERKs are inactivated	 13	0.0166995054215883	0.123606453088308	10	3	7525	9620	1.75162064213159
R-HSA-2028269	Signaling by Hippo	 20	0.54691392403667	0.867804049431875	9	11	7526	9612	1.02469807564698
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	 82	0.0174931667364502	0.126154424665511	46	36	7489	9587	1.27740139511548
R-HSA-2029481	FCGR activation	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	 58	0.0170086595601998	0.124638725701894	34	24	7501	9599	1.33485573072787
R-HSA-2029485	Role of phospholipids in phagocytosis	 23	0.596160998217299	0.925802672944902	10	13	7525	9610	0.990046449900464
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	 25	0.0130881638619638	0.109442744440838	17	8	7518	9615	1.54843264764433
R-HSA-2033514	FGFR3 mutant receptor activation	 10	0.996927117940809	1	1	9	7534	9614	0.227710683477107
R-HSA-2033519	Activated point mutants of FGFR2	 13	0.999458719063977	1	1	12	7534	9611	0.175162064213159
R-HSA-203615	eNOS activation	 12	0.236071364521815	0.534520302356683	7	5	7528	9618	1.32831232028312
R-HSA-203641	NOSTRIN mediated eNOS trafficking	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-203765	eNOS activation and regulation	 22	0.356826686917845	0.695786515406328	11	11	7524	9612	1.13855341738553
R-HSA-203927	MicroRNA (miRNA) biogenesis	 21	0.000591772676017973	0.0174069391132104	17	4	7518	9619	1.84337219957658
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	 62	0.0173137919831629	0.125524991877931	36	26	7499	9597	1.32219106535094
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	 14	0.00915995184693369	0.086701488662296	11	3	7524	9620	1.78915537017727
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	 11	0.155313269279354	0.418457570128669	7	4	7528	9619	1.44906798576341
R-HSA-2046105	Linoleic acid (LA) metabolism	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	 11	0.155313269279354	0.418457570128669	7	4	7528	9619	1.44906798576341
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	 65	0.0235957027224004	0.146853620139871	37	28	7498	9595	1.29619927517738
R-HSA-205025	NADE modulates death signalling	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-205043	NRIF signals cell death from the nucleus	 13	0.158412465982348	0.418457570128669	8	5	7527	9618	1.40129651370527
R-HSA-209543	p75NTR recruits signalling complexes	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-209560	NF-kB is activated and signals survival	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-209776	Amine-derived hormones	 10	0.972843316904817	1	2	8	7533	9615	0.455421366954214
R-HSA-209822	Glycoprotein hormones	  8	0.928935406156623	1	2	6	7533	9617	0.569276708692767
R-HSA-209952	Peptide hormone biosynthesis	 10	0.887922556996002	1	3	7	7532	9616	0.683132050431321
R-HSA-209968	Thyroxine biosynthesis	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	 24	8.63857507001382e-05	0.00546372159427944	20	4	7515	9619	1.89758902897589
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	  6	0.968899630100056	1	1	5	7534	9618	0.379517805795178
R-HSA-210745	Regulation of gene expression in beta cells	 15	0.949571630069493	1	4	11	7531	9612	0.607228489272285
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	  5	1	1	0	5	7535	9618	0
R-HSA-210990	PECAM1 interactions	 11	0.574160276360291	0.898485024889869	5	6	7530	9617	1.03504856125958
R-HSA-210991	Basigin interactions	 22	0.914849009601046	1	7	15	7528	9608	0.724533992881704
R-HSA-210993	Tie2 Signaling	 16	0.228003580421255	0.534520302356683	9	7	7526	9616	1.28087259455873
R-HSA-211000	Gene Silencing by RNA	 94	0.0438330010881644	0.197829074447577	50	44	7485	9579	1.21122703977184
R-HSA-211227	Activation of DNA fragmentation factor	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	 40	0.105176715985132	0.338103452565413	22	18	7513	9605	1.25240875912409
R-HSA-211897	Cytochrome P450 - arranged by substrate type	 44	0.930238241328632	1	15	29	7520	9594	0.776286420944682
R-HSA-211935	Fatty acids	  9	1	1	0	9	7535	9614	0
R-HSA-211945	Phase 1 - Functionalization of compounds	 80	0.958747613159615	1	28	52	7507	9571	0.796987392169874
R-HSA-211958	Miscellaneous substrates	  9	0.99451873783721	1	1	8	7534	9615	0.253011870530119
R-HSA-211976	Endogenous sterols	 19	0.802016631441832	1	7	12	7528	9611	0.83893409702092
R-HSA-211979	Eicosanoids	  9	1	1	0	9	7535	9614	0
R-HSA-211981	Xenobiotics	 15	0.949571630069493	1	4	11	7531	9612	0.607228489272285
R-HSA-211999	CYP2E1 reactions	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	 45	0.299270730572179	0.637353134015438	22	23	7513	9600	1.11325223033252
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	 27	0.0362017430938798	0.180083853419555	17	10	7518	9613	1.43373393300401
R-HSA-212300	PRC2 methylates histones and DNA	 38	0.957119547164363	1	12	26	7523	9597	0.719086368875074
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	 21	9.73209632518134e-05	0.00546372159427944	18	3	7517	9620	1.9518058583752
R-HSA-212718	EGFR interacts with phospholipase C-gamma	 35	0.233140620076135	0.534520302356683	18	17	7517	9606	1.17108351502512
R-HSA-2129379	Molecules associated with elastic fibres	 31	0.998956001465236	1	6	25	7529	9598	0.440730355116981
R-HSA-2132295	MHC class II antigen presentation	 92	0.0445040801125712	0.199536385504719	49	43	7486	9580	1.21280690112807
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	  6	0.237586605308932	0.534520302356683	4	2	7531	9621	1.51807122318071
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	 17	0.994766805679383	1	3	14	7532	9609	0.401842382606659
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-2142753	Arachidonic acid metabolism	 46	0.978512104010563	1	14	32	7521	9591	0.693032514930325
R-HSA-2142789	Ubiquinol biosynthesis	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-2142845	Hyaluronan metabolism	 15	0.949571630069493	1	4	11	7531	9612	0.607228489272285
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	 44	0.000989857739426904	0.0236697561199802	30	14	7505	9609	1.55257284188936
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-216083	Integrin cell surface interactions	 69	0.996278941392839	1	20	49	7515	9574	0.66003096660031
R-HSA-2160916	Hyaluronan uptake and degradation	 11	0.925227670384916	1	3	8	7532	9615	0.621029136755746
R-HSA-2161522	Abacavir transport and metabolism	  9	0.955859164923054	1	2	7	7533	9616	0.506023741060237
R-HSA-2161541	Abacavir metabolism	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	 13	0.993942001335532	1	2	11	7533	9612	0.350324128426318
R-HSA-2168880	Scavenging of heme from plasma	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	 37	0.998712913026768	1	8	29	7527	9594	0.492347423734285
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	 24	0.503111057915753	0.840368102866631	11	13	7524	9610	1.04367396593674
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	 30	0.449507251735669	0.787504349763132	14	16	7521	9607	1.0626498562265
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	 13	0.89345159104885	1	4	9	7531	9614	0.700648256852636
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	 42	0.170641593340054	0.441336796437371	22	20	7513	9603	1.19277024678485
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	 22	0.356826686917845	0.695786515406328	11	11	7524	9612	1.13855341738553
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	 30	0.311113753296263	0.654395132319145	15	15	7520	9608	1.13855341738553
R-HSA-2179392	EGFR Transactivation by Gastrin	  8	0.0154976542898073	0.120704587411471	7	1	7528	9622	1.99246848042468
R-HSA-2187338	Visual phototransduction	 82	0.99546546031406	1	25	57	7510	9566	0.694239888649716
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-2214320	Anchoring fibril formation	 13	0.747445650914158	1	5	8	7530	9615	0.875810321065796
R-HSA-2219528	PI3K/AKT Signaling in Cancer	 77	0.701590693678845	1	32	45	7503	9578	0.946330113151613
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	 52	0.933649360835012	1	18	34	7517	9589	0.788229288959216
R-HSA-2243919	Crosslinking of collagen fibrils	 10	0.887922556996002	1	3	7	7532	9616	0.683132050431321
R-HSA-2262749	Cellular response to hypoxia	 63	0.234955279560969	0.534520302356683	31	32	7504	9591	1.1204811409191
R-HSA-2299718	Condensation of Prophase Chromosomes	 40	0.998634813316718	1	9	31	7526	9592	0.51234903782349
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-2408517	SeMet incorporation into proteins	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-2408522	Selenoamino acid metabolism	 70	0.334274594734405	0.677975865828461	33	37	7502	9586	1.07349322210636
R-HSA-2408557	Selenocysteine synthesis	 49	0.28282199837989	0.610913444994913	24	25	7511	9598	1.11531763335726
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	 41	1.78406627112258e-06	0.000405280387923346	33	8	7502	9615	1.83279330603525
R-HSA-2428933	SHC-related events triggered by IGF1R	  9	0.043219193128198	0.195706844630345	7	2	7528	9621	1.77108309371083
R-HSA-2453864	Retinoid cycle disease events	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	 18	0.95032241456744	1	5	13	7530	9610	0.632529676325297
R-HSA-2465910	MASTL Facilitates Mitotic Progression	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-2470946	Cohesin Loading onto Chromatin	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-2474795	Diseases associated with visual transduction	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-2485179	Activation of the phototransduction cascade	 10	0.996927117940809	1	1	9	7534	9614	0.227710683477107
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	 88	0.268599429112735	0.587642089696079	42	46	7493	9577	1.08680098932256
R-HSA-2514853	Condensation of Prometaphase Chromosomes	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-2514856	The phototransduction cascade	 31	0.776849856450973	1	12	19	7523	9604	0.881460710233962
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	 30	0.729306483260043	1	12	18	7523	9605	0.910842733908427
R-HSA-2559580	Oxidative Stress Induced Senescence	 85	0.315995904246434	0.658566387596162	40	45	7495	9578	1.07157968695109
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	 71	0.982367035830746	1	23	48	7512	9575	0.737654326756825
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	 14	0.979396786509249	1	3	11	7532	9612	0.4879514645938
R-HSA-2559585	Oncogene Induced Senescence	 29	0.00567576988947412	0.0666902962013209	20	9	7515	9614	1.57041850673867
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	 53	0.998957065461915	1	13	40	7522	9583	0.558535638717432
R-HSA-2562578	TRIF-mediated programmed cell death	  9	0.99451873783721	1	1	8	7534	9615	0.253011870530119
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	  9	0.353145803414631	0.693570216216343	5	4	7530	9619	1.26505935265059
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	 81	0.00192636904443259	0.0340992338644366	49	32	7486	9591	1.3775090728862
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	 54	0.0316535648038793	0.166822306132956	31	23	7504	9600	1.30722799773895
R-HSA-2644603	Signaling by NOTCH1 in Cancer	 54	0.0316535648038793	0.166822306132956	31	23	7504	9600	1.30722799773895
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	 54	0.0316535648038793	0.166822306132956	31	23	7504	9600	1.30722799773895
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	 15	0.000830336976967527	0.0211262538524603	13	2	7522	9621	1.97349259013493
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-264876	Insulin processing	 27	0.00495781067942045	0.0603347853218756	19	8	7516	9615	1.60240851335742
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-2672351	Stimuli-sensing channels	 88	0.104024985321747	0.335191619370075	45	43	7490	9580	1.16442963141702
R-HSA-2682334	EPH-Ephrin signaling	 91	0.000522281066199589	0.0165550951913963	56	35	7479	9588	1.40129651370527
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	 14	0.232292221466613	0.534520302356683	8	6	7527	9617	1.30120390558347
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	 14	0.232292221466613	0.534520302356683	8	6	7527	9617	1.30120390558347
R-HSA-2871809	FCERI mediated Ca+2 mobilization	 32	0.707978078751549	1	13	19	7522	9604	0.925074651625747
R-HSA-2871837	FCERI mediated NF-kB activation	 71	0.101543542669682	0.332701559275904	37	34	7498	9589	1.18666130826098
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	 54	0.0316535648038793	0.166822306132956	31	23	7504	9600	1.30722799773895
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	 54	0.0316535648038793	0.166822306132956	31	23	7504	9600	1.30722799773895
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 18	0.0144331621177994	0.116404733529945	13	5	7522	9618	1.64457715844577
R-HSA-2980736	Peptide hormone metabolism	 68	0.0525802533027968	0.226078502371331	37	31	7498	9592	1.2390140130372
R-HSA-2980766	Nuclear Envelope Breakdown	 49	0.194723892108947	0.492409396928562	25	24	7510	9599	1.16178920141381
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	  7	0.98256225178826	1	1	6	7534	9617	0.325300976395867
R-HSA-2990846	SUMOylation	 99	0.0212582851833679	0.141341671731368	54	45	7481	9578	1.24205827351149
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	 11	0.155313269279354	0.418457570128669	7	4	7528	9619	1.44906798576341
R-HSA-2995410	Nuclear Envelope Reassembly	 11	0.155313269279354	0.418457570128669	7	4	7528	9619	1.44906798576341
R-HSA-3000157	Laminin interactions	 27	0.819339032357243	1	10	17	7525	9606	0.843372901767062
R-HSA-3000170	Syndecan interactions	 26	0.941644169034434	1	8	18	7527	9605	0.700648256852636
R-HSA-3000171	Non-integrin membrane-ECM interactions	 55	0.839922460720121	1	21	34	7514	9589	0.869440791458044
R-HSA-3000178	ECM proteoglycans	 61	0.86647866393304	1	23	38	7512	9585	0.858581265569419
R-HSA-3000480	Scavenging by Class A Receptors	 18	0.984949869969325	1	4	14	7531	9609	0.506023741060237
R-HSA-3000484	Scavenging by Class F Receptors	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-3065679	SUMO is proteolytically processed	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	 74	0.0176370667124954	0.126522746995428	42	32	7493	9591	1.2924119873025
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	 95	0.0216834130100639	0.143468407440374	52	43	7483	9580	1.2464163727168
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	 13	0.541597775378239	0.86541356136054	6	7	7529	9616	1.05097238527895
R-HSA-3214815	HDACs deacetylate histones	 53	0.993476767949641	1	15	38	7520	9585	0.644464198520114
R-HSA-3214841	PKMTs methylate histone lysines	 49	0.0109363989997227	0.0987172969312721	30	19	7505	9604	1.39414704169657
R-HSA-3214842	HDMs demethylate histones	 31	0.933792227169568	1	10	21	7525	9602	0.734550591861635
R-HSA-3214847	HATs acetylate histones	 99	0.153812718636722	0.418457570128669	49	50	7486	9573	1.12705287781598
R-HSA-3214858	RMTs methylate histone arginines	 44	0.708608900251563	1	18	26	7517	9597	0.931543705133619
R-HSA-3215018	Processing and activation of SUMO	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-3229121	Glycogen storage diseases	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-3232118	SUMOylation of transcription factors	 15	0.15976668396887	0.418457570128669	9	6	7526	9617	1.36626410086264
R-HSA-3238698	WNT ligand biogenesis and trafficking	 20	0.993572792855964	1	4	16	7531	9607	0.455421366954214
R-HSA-3270619	IRF3-mediated induction of type I IFN	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-3295583	TRP channels	 21	0.77405711321654	1	8	13	7527	9610	0.867469270388978
R-HSA-3296469	Defects in cobalamin (B12) metabolism	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-3296482	Defects in vitamin and cofactor metabolism	 15	0.15976668396887	0.418457570128669	9	6	7526	9617	1.36626410086264
R-HSA-3299685	Detoxification of Reactive Oxygen Species	 32	0.818172923070628	1	12	20	7523	9603	0.853915063039151
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	 34	0.10889972412387	0.341462890835091	19	15	7516	9608	1.27250087825442
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-3322077	Glycogen synthesis	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-3323169	Defects in biotin (Btn) metabolism	  6	0.0621040375419129	0.247508196402419	5	1	7530	9622	1.89758902897589
R-HSA-3371378	Regulation by c-FLIP	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	 74	0.00250255817166587	0.0410962263612118	45	29	7490	9594	1.38472712925268
R-HSA-3371511	HSF1 activation	 25	0.154675852577038	0.418457570128669	14	11	7521	9612	1.2751798274718
R-HSA-3371556	Cellular response to heat stress	 93	0.00111112092888684	0.0252409637678795	56	37	7479	9586	1.37116110480839
R-HSA-3371568	Attenuation phase	 22	0.688271289905648	0.995874488472821	9	13	7526	9610	0.931543705133619
R-HSA-3371571	HSF1-dependent transactivation	 32	0.707978078751549	1	13	19	7522	9604	0.925074651625747
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	  6	0.0621040375419129	0.247508196402419	5	1	7530	9622	1.89758902897589
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	 42	0.103786915776897	0.335191619370075	23	19	7512	9604	1.24698707618416
R-HSA-350054	Notch-HLH transcription pathway	 13	0.158412465982348	0.418457570128669	8	5	7527	9618	1.40129651370527
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	 42	0.260151462600343	0.575627343383552	21	21	7514	9602	1.13855341738553
R-HSA-351202	Metabolism of polyamines	 68	0.53335657089762	0.861237493041779	30	38	7505	9585	1.00460595651665
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	  8	0.990223229735637	1	1	7	7534	9616	0.284638354346384
R-HSA-352230	Amino acid transport across the plasma membrane	 26	0.941644169034434	1	8	18	7527	9605	0.700648256852636
R-HSA-354192	Integrin alphaIIb beta3 signaling	 24	0.895889936693685	1	8	16	7527	9607	0.759035611590356
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	 24	0.798400933383154	1	9	15	7526	9608	0.853915063039151
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	 19	0.648233602275884	0.975221233468183	8	11	7527	9612	0.958781825166766
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	 19	0.648233602275884	0.975221233468183	8	11	7527	9612	0.958781825166766
R-HSA-3595172	Defective CHST3 causes SEDCJD	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-3595177	Defective CHSY1 causes TPBS	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-3656225	Defective CHST6 causes MCDC1	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-3656237	Defective EXT2 causes exostoses 2	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-373080	Class B/2 (Secretin family receptors)	 71	0.96839234015594	1	24	47	7511	9576	0.769726254007122
R-HSA-373752	Netrin-1 signaling	 39	0.00877776582025374	0.0860726245539989	25	14	7510	9609	1.45968386844299
R-HSA-373753	Nephrin interactions	 21	0.77405711321654	1	8	13	7527	9610	0.867469270388978
R-HSA-373755	Semaphorin interactions	 61	0.168625589961187	0.438619616635683	31	30	7504	9593	1.15721822750661
R-HSA-375170	CDO in myogenesis	 27	0.551846859400684	0.870563969170291	12	15	7523	9608	1.01204748212047
R-HSA-375280	Amine ligand-binding receptors	 30	0.999935366078838	1	4	26	7531	9597	0.303614244636142
R-HSA-375281	Hormone ligand-binding receptors	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-376172	DSCAM interactions	 11	0.0524841172200018	0.226078502371331	8	3	7527	9620	1.65607769801532
R-HSA-376176	Signaling by Robo receptor	 30	0.0100457154330467	0.0918946988942463	20	10	7515	9613	1.51807122318071
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	 39	0.0201001981282549	0.138962861743972	24	15	7511	9608	1.40129651370527
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	 12	0.950794665049215	1	3	9	7532	9614	0.569276708692767
R-HSA-3781865	Diseases of glycosylation	 67	0.975928172158525	1	22	45	7513	9578	0.747706721865127
R-HSA-3785653	Myoclonic epilepsy of Lafora	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-379716	Cytosolic tRNA aminoacylation	 23	0.0116385738253352	0.103682196888444	16	7	7519	9616	1.58407431984074
R-HSA-379724	tRNA Aminoacylation	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-379726	Mitochondrial tRNA aminoacylation	 20	0.71578005443536	1	8	12	7527	9611	0.910842733908427
R-HSA-380108	Chemokine receptors bind chemokines	 34	0.999707049149135	1	6	28	7529	9595	0.401842382606659
R-HSA-380259	Loss of Nlp from mitotic centrosomes	 65	0.00142313530476078	0.0293899003089233	41	24	7494	9599	1.4363289265479
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	 80	0.00270479991773404	0.0433722622102529	48	32	7487	9591	1.36626410086264
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	 65	0.00142313530476078	0.0293899003089233	41	24	7494	9599	1.4363289265479
R-HSA-380287	Centrosome maturation	 80	0.00270479991773404	0.0433722622102529	48	32	7487	9591	1.36626410086264
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	 22	0.356826686917845	0.695786515406328	11	11	7524	9612	1.13855341738553
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	 27	0.000357979434773845	0.0125109222973526	21	6	7514	9617	1.77108309371083
R-HSA-380994	ATF4 activates genes	 24	0.0207985501069482	0.138962861743972	16	8	7519	9615	1.51807122318071
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	 10	0.0232231889757075	0.146506213373903	8	2	7527	9621	1.82168546781685
R-HSA-381038	XBP1(S) activates chaperone genes	 49	0.194723892108947	0.492409396928562	25	24	7510	9599	1.16178920141381
R-HSA-381042	PERK regulates gene expression	 27	0.0792385101929455	0.281746548061106	16	11	7519	9612	1.3493966428273
R-HSA-381070	IRE1alpha activates chaperones	 51	0.275126795950507	0.59778608451319	25	26	7510	9597	1.11622884057405
R-HSA-381119	Unfolded Protein Response (UPR)	 81	0.0229477077553753	0.146506213373903	45	36	7490	9587	1.26505935265059
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	  8	0.0786434095133959	0.281746548061106	6	2	7529	9621	1.7078301260783
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	 80	0.223014000851003	0.534520302356683	39	41	7496	9582	1.1100895819509
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	 17	0.994766805679383	1	3	14	7532	9609	0.401842382606659
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	 38	0.0582038404310951	0.238233737260008	22	16	7513	9607	1.3183250096043
R-HSA-381753	Olfactory Signaling Pathway	 45	0.994542826744389	1	12	33	7523	9590	0.607228489272285
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	 13	0.0166995054215883	0.123606453088308	10	3	7525	9620	1.75162064213159
R-HSA-382556	ABC-family proteins mediated transport	 89	0.123315266123193	0.362238594236878	45	44	7490	9579	1.15134615241234
R-HSA-383280	Nuclear Receptor transcription pathway	 46	0.864932762099624	1	17	29	7518	9594	0.841539482415395
R-HSA-388841	Costimulation by the CD28 family	 57	0.345828423916797	0.689128862278647	27	30	7508	9593	1.07862955331261
R-HSA-389356	CD28 co-stimulation	 31	0.513433017434433	0.849718270077214	14	17	7521	9606	1.02837082860629
R-HSA-389357	CD28 dependent PI3K/Akt signaling	 20	0.71578005443536	1	8	12	7527	9611	0.910842733908427
R-HSA-389359	CD28 dependent Vav1 pathway	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-389513	CTLA4 inhibitory signaling	 21	0.0301761636267981	0.166822306132956	14	7	7521	9616	1.51807122318071
R-HSA-389599	Alpha-oxidation of phytanate	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-389661	Glyoxylate metabolism and glycine degradation	 20	0.370598850724014	0.699620822073174	10	10	7525	9613	1.13855341738553
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-389948	PD-1 signaling	 15	0.986853075619188	1	3	12	7532	9611	0.455421366954214
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	 24	0.0520301713650008	0.226078502371331	15	9	7520	9614	1.42319177173192
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	 26	0.111836572080748	0.341462890835091	15	11	7520	9612	1.31371548159869
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	 20	0.218758429843316	0.534520302356683	11	9	7524	9614	1.25240875912409
R-HSA-389977	Post-chaperonin tubulin folding pathway	 17	0.159953333849623	0.418457570128669	10	7	7525	9616	1.33947460868886
R-HSA-390247	Beta-oxidation of very long chain fatty acids	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-390450	Folding of actin by CCT/TriC	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-390466	Chaperonin-mediated protein folding	 79	0.061458701395619	0.247508196402419	42	37	7493	9586	1.21061376025804
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	 35	0.233140620076135	0.534520302356683	18	17	7517	9606	1.17108351502512
R-HSA-390522	Striated Muscle Contraction	 25	0.841228044852651	1	9	16	7526	9607	0.819758460517585
R-HSA-390666	Serotonin receptors	  9	0.99451873783721	1	1	8	7534	9615	0.253011870530119
R-HSA-390696	Adrenoceptors	  8	1	1	0	8	7535	9615	0
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	 43	0.976953820959189	1	13	30	7522	9593	0.688427647721486
R-HSA-390918	Peroxisomal lipid metabolism	 28	0.616183150302867	0.942601160339851	12	16	7523	9607	0.975902929187601
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	 13	0.326673412817859	0.671374446718672	7	6	7528	9617	1.22613444949211
R-HSA-391251	Protein folding	 85	0.0226321060460582	0.146506213373903	47	38	7488	9585	1.25910613216753
R-HSA-391903	Eicosanoid ligand-binding receptors	 12	0.950794665049215	1	3	9	7532	9614	0.569276708692767
R-HSA-391908	Prostanoid ligand receptors	  9	0.955859164923054	1	2	7	7533	9616	0.506023741060237
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	 23	0.596160998217299	0.925802672944902	10	13	7525	9610	0.990046449900464
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	 18	0.223444995996434	0.534520302356683	10	8	7525	9615	1.26505935265059
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	 40	0.630672486429095	0.96248382637886	17	23	7518	9600	0.967770404777704
R-HSA-392517	Rap1 signalling	 15	0.513696151536041	0.849718270077214	7	8	7528	9615	1.0626498562265
R-HSA-392518	Signal amplification	 28	0.321398795397976	0.665754647610092	14	14	7521	9609	1.13855341738553
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	 16	0.106693542283681	0.338982046929272	10	6	7525	9617	1.42319177173192
R-HSA-3928662	EPHB-mediated forward signaling	 41	0.0013980192291437	0.0293899003089233	28	13	7507	9610	1.55509735057536
R-HSA-3928663	EPHA-mediated growth cone collapse	 32	0.818172923070628	1	12	20	7523	9603	0.853915063039151
R-HSA-3928664	Ephrin signaling	 18	0.385675219632249	0.705228057906781	9	9	7526	9614	1.13855341738553
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	 46	0.00692768564921301	0.0755394843190186	29	17	7506	9606	1.43556735235567
R-HSA-397795	G-protein beta:gamma signalling	 43	0.662693717907292	0.975221233468183	18	25	7517	9598	0.953207512229749
R-HSA-399719	Trafficking of AMPA receptors	 29	0.000108338270839031	0.00546907641309628	23	6	7512	9617	1.80598128274947
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	 29	0.000108338270839031	0.00546907641309628	23	6	7512	9617	1.80598128274947
R-HSA-399954	Sema3A PAK dependent Axon repulsion	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	 12	0.442401915734987	0.779061771507477	6	6	7529	9617	1.13855341738553
R-HSA-399956	CRMPs in Sema3A signaling	 14	0.232292221466613	0.534520302356683	8	6	7527	9617	1.30120390558347
R-HSA-399997	Acetylcholine regulates insulin secretion	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	 25	0.078316573265455	0.281746548061106	15	10	7520	9613	1.36626410086264
R-HSA-400253	Circadian Clock	 67	0.10560081026524	0.338668010332994	35	32	7500	9591	1.18953342114907
R-HSA-400451	Free fatty acids regulate insulin secretion	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-400508	Incretin synthesis, secretion, and inactivation	 13	0.0166995054215883	0.123606453088308	10	3	7525	9620	1.75162064213159
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	  8	0.0154976542898073	0.120704587411471	7	1	7528	9622	1.99246848042468
R-HSA-400685	Sema4D in semaphorin signaling	 26	0.638652144173975	0.969357319052482	11	15	7524	9608	0.963391353172375
R-HSA-4085001	Sialic acid metabolism	 31	0.513433017434433	0.849718270077214	14	17	7521	9606	1.02837082860629
R-HSA-4086398	Ca2+ pathway	 59	0.0122685850773255	0.106510072996144	35	24	7500	9599	1.35082608842352
R-HSA-4086400	PCP/CE pathway	 80	0.0485819046120758	0.216395869236142	43	37	7492	9586	1.22394492368945
R-HSA-416482	G alpha (12/13) signalling events	 76	0.169605441900451	0.440328032972027	38	38	7497	9585	1.13855341738553
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	 23	0.596160998217299	0.925802672944902	10	13	7525	9610	0.990046449900464
R-HSA-416700	Other semaphorin interactions	 16	0.40235351964967	0.726368009645695	8	8	7527	9615	1.13855341738553
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	 15	0.000830336976967527	0.0211262538524603	13	2	7522	9621	1.97349259013493
R-HSA-417957	P2Y receptors	  9	0.955859164923054	1	2	7	7533	9616	0.506023741060237
R-HSA-418038	Nucleotide-like (purinergic) receptors	 12	0.950794665049215	1	3	9	7532	9614	0.569276708692767
R-HSA-418217	G beta:gamma signalling through PLC beta	 17	0.159953333849623	0.418457570128669	10	7	7525	9616	1.33947460868886
R-HSA-418346	Platelet homeostasis	 81	0.134510060051455	0.388426296292655	41	40	7494	9583	1.15260963241499
R-HSA-418359	Reduction of cytosolic Ca++ levels	 14	0.632005153785091	0.96248382637886	6	8	7529	9615	0.975902929187601
R-HSA-418360	Platelet calcium homeostasis	 26	0.638652144173975	0.969357319052482	11	15	7524	9608	0.963391353172375
R-HSA-418457	cGMP effects	 17	0.831347184228978	1	6	11	7529	9612	0.803684765213318
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	 22	0.214031188888199	0.528486431983	12	10	7523	9613	1.24205827351149
R-HSA-418597	G alpha (z) signalling events	 41	0.560643622265754	0.882398680309725	18	23	7517	9600	0.999705439655591
R-HSA-418885	DCC mediated attractive signaling	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-418886	Netrin mediated repulsion signals	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-418889	Ligand-independent caspase activation via DCC	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-418890	Role of second messengers in netrin-1 signaling	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-418990	Adherens junctions interactions	 30	0.837536533235356	1	11	19	7524	9604	0.834939172749392
R-HSA-419037	NCAM1 interactions	 38	0.393035350752387	0.713325143908794	18	20	7517	9603	1.07862955331261
R-HSA-419408	Lysosphingolipid and LPA receptors	 13	0.89345159104885	1	4	9	7531	9614	0.700648256852636
R-HSA-419812	Calcitonin-like ligand receptors	  8	0.990223229735637	1	1	7	7534	9616	0.284638354346384
R-HSA-420029	Tight junction interactions	 21	0.995845516065452	1	4	17	7531	9606	0.433734635194489
R-HSA-420092	Glucagon-type ligand receptors	 23	0.430249372091701	0.768584396017023	11	12	7524	9611	1.08905109489051
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	 18	0.572165618600132	0.898458223677397	8	10	7527	9613	1.01204748212047
R-HSA-420597	Nectin/Necl  trans heterodimerization	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-421270	Cell-cell junction organization	 51	0.988434629878919	1	15	36	7520	9587	0.669737304344432
R-HSA-421837	Clathrin derived vesicle budding	 64	5.35944006147428e-06	0.000831940432382631	46	18	7489	9605	1.63667053749171
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-422356	Regulation of insulin secretion	 74	0.00967661490039248	0.0903371651317462	43	31	7492	9592	1.32318370128589
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	 84	0.921309298578186	1	31	53	7504	9570	0.840360855689323
R-HSA-425381	Bicarbonate transporters	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	 90	0.803873623141071	1	36	54	7499	9569	0.910842733908427
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	 32	0.434042088890645	0.772322933626566	15	17	7520	9606	1.06739382879894
R-HSA-425410	Metal ion SLC transporters	 23	0.276729212182729	0.598701454293746	12	11	7523	9612	1.18805573988056
R-HSA-425561	Sodium/Calcium exchangers	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-425986	Sodium/Proton exchangers	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-426048	Arachidonate production from DAG	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-426117	Cation-coupled Chloride cotransporters	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	  9	0.00757721462169577	0.0789697739899982	8	1	7527	9622	2.02409496424095
R-HSA-426496	Post-transcriptional silencing by small RNAs	  7	0.003145118666278	0.0487135993424649	7	0	7528	9623	2.27710683477107
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	 34	0.998819308000393	1	7	27	7528	9596	0.468816113041102
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	 42	0.994395717311904	1	11	31	7524	9592	0.596385123392423
R-HSA-427413	NoRC negatively regulates rRNA expression	 70	0.521198458549987	0.861083029095312	31	39	7504	9584	1.00843302682719
R-HSA-427601	Multifunctional anion exchangers	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-428157	Sphingolipid metabolism	 78	0.228439149907832	0.534520302356683	38	40	7497	9583	1.10935974001667
R-HSA-428540	Activation of Rac	 13	0.0596391965049837	0.24121134966259	9	4	7526	9619	1.57645857791843
R-HSA-428543	Inactivation of Cdc42 and Rac	  8	0.0154976542898073	0.120704587411471	7	1	7528	9622	1.99246848042468
R-HSA-428643	Organic anion transporters	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-428790	Facilitative Na+-independent glucose transporters	 11	0.998277372566188	1	1	10	7534	9613	0.207009712251915
R-HSA-428890	Role of Abl in Robo-Slit signaling	  9	0.043219193128198	0.195706844630345	7	2	7528	9621	1.77108309371083
R-HSA-428930	Thromboxane signalling through TP receptor	 20	0.110715314015332	0.341462890835091	12	8	7523	9615	1.36626410086264
R-HSA-429593	Inositol transporters	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-429914	Deadenylation-dependent mRNA decay	 52	0.00350735162407762	0.0511746481943655	33	19	7502	9604	1.44508702975856
R-HSA-429947	Deadenylation of mRNA	 22	0.214031188888199	0.528486431983	12	10	7523	9613	1.24205827351149
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	 16	0.0118802379338547	0.104469447121574	12	4	7523	9619	1.7078301260783
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	 14	0.10300264936915	0.333474135606059	9	5	7526	9618	1.4638543937814
R-HSA-430116	GP1b-IX-V activation signalling	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	 39	0.57760264360431	0.902835324808114	17	22	7518	9601	0.992585030541235
R-HSA-432047	Passive transport by Aquaporins	  9	0.99451873783721	1	1	8	7534	9615	0.253011870530119
R-HSA-432142	Platelet sensitization by LDL	 16	0.040239810047395	0.190440489911803	11	5	7524	9618	1.56551094890511
R-HSA-432720	Lysosome Vesicle Biogenesis	 30	0.00349079711768782	0.0511746481943655	21	9	7514	9614	1.59397478433975
R-HSA-432722	Golgi Associated Vesicle Biogenesis	 49	0.000275315638253302	0.0107215775696929	34	15	7501	9608	1.58003331392278
R-HSA-433692	Proton-coupled monocarboxylate transport	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-435354	Zinc transporters	 15	0.315178550035463	0.657868857118432	8	7	7527	9616	1.21445697854457
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-437239	Recycling pathway of L1	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-438064	Post NMDA receptor activation events	 36	0.0124581844785199	0.10679563172467	23	13	7512	9610	1.45481825554818
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	 16	0.106693542283681	0.338982046929272	10	6	7525	9617	1.42319177173192
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	 14	0.811579260430306	1	5	9	7530	9614	0.813252440989667
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 19	0.648233602275884	0.975221233468183	8	11	7527	9612	0.958781825166766
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	 15	0.513696151536041	0.849718270077214	7	8	7528	9615	1.0626498562265
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	  6	0.0621040375419129	0.247508196402419	5	1	7530	9622	1.89758902897589
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	 16	0.040239810047395	0.190440489911803	11	5	7524	9618	1.56551094890511
R-HSA-442742	CREB phosphorylation through the activation of Ras	 28	0.00910995155322843	0.086701488662296	19	9	7516	9614	1.54517963788037
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	 40	0.0137455086244711	0.113546231849419	25	15	7510	9608	1.42319177173192
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	 18	0.0144331621177994	0.116404733529945	13	5	7522	9618	1.64457715844577
R-HSA-444257	RSK activation	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-445095	Interaction between L1 and Ankyrins	 27	0.152584149440501	0.418457570128669	15	12	7520	9611	1.26505935265059
R-HSA-445144	Signal transduction by L1	 18	0.385675219632249	0.705228057906781	9	9	7526	9614	1.13855341738553
R-HSA-445355	Smooth Muscle Contraction	 33	0.756383766817205	1	13	20	7522	9603	0.897042086424966
R-HSA-445717	Aquaporin-mediated transport	 44	0.708608900251563	1	18	26	7517	9597	0.931543705133619
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	 28	0.466065138197773	0.800629181213145	13	15	7522	9608	1.05722817328657
R-HSA-446107	Type I hemidesmosome assembly	  9	0.955859164923054	1	2	7	7533	9616	0.506023741060237
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	 71	0.374348949999368	0.704748092333064	33	38	7502	9585	1.05837359925979
R-HSA-446199	Synthesis of Dolichyl-phosphate	  6	0.237586605308932	0.534520302356683	4	2	7531	9621	1.51807122318071
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	 60	0.286528196388261	0.61405335169371	29	31	7506	9592	1.10060163680602
R-HSA-446353	Cell-extracellular matrix interactions	 17	0.831347184228978	1	6	11	7529	9612	0.803684765213318
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-446652	Interleukin-1 signaling	 39	0.327067228628906	0.671374446718672	19	20	7516	9603	1.10935974001667
R-HSA-446728	Cell junction organization	 75	0.99847744791795	1	21	54	7514	9569	0.637589913735899
R-HSA-447038	NrCAM interactions	  7	0.0312840930957045	0.166822306132956	6	1	7529	9622	1.9518058583752
R-HSA-447041	CHL1 interactions	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-447043	Neurofascin interactions	  7	0.0312840930957045	0.166822306132956	6	1	7529	9622	1.9518058583752
R-HSA-448424	Interleukin-17 signaling	  7	0.98256225178826	1	1	6	7534	9617	0.325300976395867
R-HSA-448706	Interleukin-1 processing	  5	1	1	0	5	7535	9618	0
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	 31	0.00636680197172346	0.0729239587181435	21	10	7514	9613	1.54255624290943
R-HSA-450294	MAP kinase activation in TLR cascade	 60	0.00419875822235906	0.0569644545424945	37	23	7498	9600	1.40421588144216
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	 20	0.370598850724014	0.699620822073174	10	10	7525	9613	1.13855341738553
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	 19	0.0726693044916316	0.275900451315025	12	7	7523	9616	1.43817273775015
R-HSA-450341	Activation of the AP-1 family of transcription factors	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	 17	0.069411688187522	0.268773099430661	11	6	7524	9617	1.47342206955775
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	 44	0.166847427180969	0.434824174469714	23	21	7512	9602	1.19030584544851
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	 16	0.040239810047395	0.190440489911803	11	5	7524	9618	1.56551094890511
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	  7	0.139153898657434	0.395964016430236	5	2	7530	9621	1.62650488197933
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	 74	0.00504890844516153	0.0608996655819042	44	30	7491	9593	1.35395541526928
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	 17	0.00669372185778721	0.0735769588077739	13	4	7522	9619	1.74131699129552
R-HSA-451306	Ionotropic activity of Kainate Receptors	 12	0.236071364521815	0.534520302356683	7	5	7528	9618	1.32831232028312
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	 12	0.236071364521815	0.534520302356683	7	5	7528	9618	1.32831232028312
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	 29	0.0798225779040592	0.281746548061106	17	12	7518	9611	1.33485573072787
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	 32	0.434042088890645	0.772322933626566	15	17	7520	9606	1.06739382879894
R-HSA-453276	Regulation of mitotic cell cycle	 72	0.0812871327141308	0.284088107408616	38	34	7497	9589	1.20180638501806
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	 27	0.152584149440501	0.418457570128669	15	12	7520	9611	1.26505935265059
R-HSA-4570464	SUMOylation of RNA binding proteins	 44	0.102349324950043	0.332940644169233	24	20	7511	9603	1.24205827351149
R-HSA-4608870	Asymmetric localization of PCP proteins	 54	0.221575052966385	0.534520302356683	27	27	7508	9596	1.13855341738553
R-HSA-4615885	SUMOylation of DNA replication proteins	 43	0.133132510105712	0.385264567460905	23	20	7512	9603	1.21798737673801
R-HSA-4641257	Degradation of AXIN	 45	0.130660049734355	0.37891414422963	24	21	7511	9602	1.21445697854457
R-HSA-4641258	Degradation of DVL	 47	0.199612497796341	0.502186080663988	24	23	7511	9600	1.16277795818097
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	 29	0.150342744908067	0.418457570128669	16	13	7519	9610	1.25633480539093
R-HSA-4641263	Regulation of FZD by ubiquitination	 19	0.467572141045975	0.800629181213145	9	10	7526	9613	1.07862955331261
R-HSA-4641265	Repression of WNT target genes	 14	0.632005153785091	0.96248382637886	6	8	7529	9615	0.975902929187601
R-HSA-4791275	Signaling by WNT in cancer	 31	0.0801283337107708	0.281746548061106	18	13	7517	9610	1.32219106535094
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	 22	0.688271289905648	0.995874488472821	9	13	7526	9610	0.931543705133619
R-HSA-500657	Presynaptic function of Kainate receptors	 18	0.223444995996434	0.534520302356683	10	8	7525	9615	1.26505935265059
R-HSA-500753	Pyrimidine biosynthesis	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	 10	1	1	0	10	7535	9613	0
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	 10	1	1	0	10	7535	9613	0
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	 28	0.751485124436804	1	11	17	7524	9606	0.894577685088634
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	 10	1	1	0	10	7535	9613	0
R-HSA-5099900	WNT5A-dependent internalization of FZD4	 15	0.0049480782569692	0.0603347853218756	12	3	7523	9620	1.82168546781685
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	 12	0.029911718062633	0.166406823344362	9	3	7526	9620	1.7078301260783
R-HSA-5173105	O-linked glycosylation	 95	0.933661444834554	1	35	60	7500	9563	0.83893409702092
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	 30	0.729306483260043	1	12	18	7523	9605	0.910842733908427
R-HSA-5205647	Mitophagy	 18	0.00371701406547482	0.0511746481943655	14	4	7521	9619	1.77108309371083
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	 18	0.00371701406547482	0.0511746481943655	14	4	7521	9619	1.77108309371083
R-HSA-5210891	Uptake and function of anthrax toxins	 13	0.158412465982348	0.418457570128669	8	5	7527	9618	1.40129651370527
R-HSA-5213460	RIPK1-mediated regulated necrosis	 19	0.907721351173715	1	6	13	7529	9610	0.719086368875074
R-HSA-5218859	Regulated Necrosis	 19	0.907721351173715	1	6	13	7529	9610	0.719086368875074
R-HSA-5218900	CASP8 activity is inhibited	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-5218920	VEGFR2 mediated vascular permeability	 29	0.384923619130613	0.705228057906781	14	15	7521	9608	1.09929295471707
R-HSA-5223345	Miscellaneous transport and binding events	 17	0.069411688187522	0.268773099430661	11	6	7524	9617	1.47342206955775
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	 71	0.654713512362371	0.975221233468183	30	41	7505	9582	0.962157817508902
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	 56	0.797296278045885	1	22	34	7513	9589	0.894577685088634
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	 73	0.550560308584863	0.870563969170291	32	41	7503	9582	0.998183817981838
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-525793	Myogenesis	 27	0.551846859400684	0.870563969170291	12	15	7523	9608	1.01204748212047
R-HSA-5260271	Diseases of Immune System	 22	0.966085719504022	1	6	16	7529	9607	0.621029136755746
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	 32	1.70139802504442e-05	0.00231900550813555	26	6	7509	9617	1.85014930325149
R-HSA-5334118	DNA methylation	 30	0.9996373594079	1	5	25	7530	9598	0.379517805795178
R-HSA-5336415	Uptake and function of diphtheria toxin	  6	0.237586605308932	0.534520302356683	4	2	7531	9621	1.51807122318071
R-HSA-5339562	Uptake and actions of bacterial toxins	 29	0.00178286385578079	0.0319742557293318	21	8	7514	9615	1.6489394320756
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	 26	0.941644169034434	1	8	18	7527	9605	0.700648256852636
R-HSA-5357786	TNFR1-induced proapoptotic signaling	 13	0.89345159104885	1	4	9	7531	9614	0.700648256852636
R-HSA-5357905	Regulation of TNFR1 signaling	 29	0.150342744908067	0.418457570128669	16	13	7519	9610	1.25633480539093
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	 26	0.204655013156044	0.510015377016987	14	12	7521	9611	1.22613444949211
R-HSA-5358346	Hedgehog ligand biogenesis	 55	0.260670893274382	0.575841859858966	27	28	7508	9595	1.11785244616034
R-HSA-5358493	Synthesis of diphthamide-EEF2	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-5358508	Mismatch Repair	 13	0.541597775378239	0.86541356136054	6	7	7529	9616	1.05097238527895
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	 12	0.442401915734987	0.779061771507477	6	6	7529	9617	1.13855341738553
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 15	0.020742604219336	0.138962861743972	11	4	7524	9619	1.66987834549878
R-HSA-5362517	Signaling by Retinoic Acid	 35	0.233140620076135	0.534520302356683	18	17	7517	9606	1.17108351502512
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	 46	0.0580068850563216	0.238233737260008	26	20	7509	9603	1.2870603848706
R-HSA-5362798	Release of Hh-Np from the secreting cell	  8	0.990223229735637	1	1	7	7534	9616	0.284638354346384
R-HSA-5365859	RA biosynthesis pathway	 17	0.489280996836629	0.830498130371513	8	9	7527	9614	1.07157968695109
R-HSA-5368286	Mitochondrial translation initiation	 76	0.00122610220799555	0.0266772083572533	47	29	7488	9594	1.40821080571369
R-HSA-5368287	Mitochondrial translation	 82	0.00012200411614365	0.00593898608227837	53	29	7482	9594	1.4717885639374
R-HSA-5387390	Hh mutants abrogate ligand secretion	 48	0.0993758478089954	0.326383808587134	26	22	7509	9601	1.23343286883433
R-HSA-5389840	Mitochondrial translation elongation	 76	9.65962771313761e-05	0.00546372159427944	50	26	7485	9597	1.49809660182307
R-HSA-5419276	Mitochondrial translation termination	 76	9.65962771313761e-05	0.00546372159427944	50	26	7485	9597	1.49809660182307
R-HSA-5423646	Aflatoxin activation and detoxification	 17	0.929216442010831	1	5	12	7530	9611	0.669737304344432
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-549127	Organic cation transport	  8	0.928935406156623	1	2	6	7533	9617	0.569276708692767
R-HSA-549132	Organic cation/anion/zwitterion transport	 12	0.989950553014577	1	2	10	7533	9613	0.379517805795178
R-HSA-5576886	Phase 4 - resting membrane potential	 15	0.986853075619188	1	3	12	7532	9611	0.455421366954214
R-HSA-5576890	Phase 3 - rapid repolarisation	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-5576892	Phase 0 - rapid depolarisation	 39	0.138122683673083	0.395506760181538	21	18	7514	9605	1.22613444949211
R-HSA-5576893	Phase 2 - plateau phase	 21	0.285428937903023	0.612660854113103	11	10	7524	9613	1.19277024678485
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	  7	0.368830214177596	0.699620822073174	4	3	7531	9620	1.30120390558347
R-HSA-5578749	Transcriptional regulation by small RNAs	 69	0.383820570906169	0.705228057906781	32	37	7503	9586	1.0560495465605
R-HSA-5578768	Physiological factors	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-5578775	Ion homeostasis	 51	0.275126795950507	0.59778608451319	25	26	7510	9597	1.11622884057405
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	  5	1	1	0	5	7535	9618	0
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	 23	0.032510408078718	0.169128573325544	15	8	7520	9615	1.4850696748507
R-HSA-5602358	Diseases associated with the TLR signaling cascade	 22	0.966085719504022	1	6	16	7529	9607	0.621029136755746
R-HSA-5602498	MyD88 deficiency (TLR2/4)	 10	0.996927117940809	1	1	9	7534	9614	0.227710683477107
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-5603029	IkBA variant leads to EDA-ID	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	 10	0.996927117940809	1	1	9	7534	9614	0.227710683477107
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	 52	0.227372804651369	0.534520302356683	26	26	7509	9597	1.13855341738553
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	 13	0.0596391965049837	0.24121134966259	9	4	7526	9619	1.57645857791843
R-HSA-5607764	CLEC7A (Dectin-1) signaling	 89	0.123315266123193	0.362238594236878	45	44	7490	9579	1.15134615241234
R-HSA-5610780	Degradation of GLI1 by the proteasome	 50	0.0573993986627678	0.238233737260008	28	22	7507	9601	1.2751798274718
R-HSA-5610783	Degradation of GLI2 by the proteasome	 50	0.0573993986627678	0.238233737260008	28	22	7507	9601	1.2751798274718
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	 50	0.0978577945122039	0.32217433314042	27	23	7508	9600	1.22963769077638
R-HSA-5610787	Hedgehog 'off' state	 98	0.0271163768947456	0.163452700710687	53	45	7482	9578	1.23149655349864
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	 77	0.839634526599074	1	30	47	7505	9576	0.887184481079637
R-HSA-5619084	ABC transporter disorders	 55	0.118720393473002	0.356562653199804	29	26	7506	9597	1.20065633106111
R-HSA-5619102	SLC transporter disorders	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-5619115	Disorders of transmembrane transporters	 60	0.205419218240096	0.510924077484035	30	30	7505	9593	1.13855341738553
R-HSA-5619507	Activation of HOX genes during differentiation	 77	0.839634526599074	1	30	47	7505	9576	0.887184481079637
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	 90	0.00151701136964173	0.0294752474269789	54	36	7481	9587	1.36626410086264
R-HSA-5620916	VxPx cargo-targeting to cilium	 20	0.0167771047845465	0.123606453088308	14	6	7521	9617	1.59397478433975
R-HSA-5620920	Cargo trafficking to the periciliary membrane	 47	0.00466262700972075	0.0603347853218756	30	17	7505	9606	1.45347244772621
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	 20	0.110715314015332	0.341462890835091	12	8	7523	9615	1.36626410086264
R-HSA-5620924	Intraflagellar transport	 48	0.00122286813728611	0.0266772083572533	32	16	7503	9607	1.51807122318071
R-HSA-5621480	Dectin-2 family	 18	0.999547430524568	1	2	16	7533	9607	0.253011870530119
R-HSA-5621575	CD209 (DC-SIGN) signaling	 21	0.285428937903023	0.612660854113103	11	10	7524	9613	1.19277024678485
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-5625740	RHO GTPases activate PKNs	 58	0.992264502649299	1	17	41	7518	9582	0.667427865363934
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	 33	0.999906671279957	1	5	28	7530	9595	0.345016187086526
R-HSA-5625900	RHO GTPases activate CIT	 15	0.513696151536041	0.849718270077214	7	8	7528	9615	1.0626498562265
R-HSA-5625970	RHO GTPases activate KTN1	 11	0.574160276360291	0.898485024889869	5	6	7530	9617	1.03504856125958
R-HSA-5626467	RHO GTPases activate IQGAPs	 24	0.0207985501069482	0.138962861743972	16	8	7519	9615	1.51807122318071
R-HSA-5626978	TNFR1-mediated ceramide production	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-5627117	RHO GTPases Activate ROCKs	 17	0.831347184228978	1	6	11	7529	9612	0.803684765213318
R-HSA-5627123	RHO GTPases activate PAKs	 23	0.156558000868215	0.418457570128669	13	10	7522	9613	1.2870603848706
R-HSA-5628897	TP53 Regulates Metabolic Genes	 81	3.30999091445045e-08	2.25575880819798e-05	60	21	7475	9602	1.68674580353412
R-HSA-5632681	Ligand-receptor interactions	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-5632684	Hedgehog 'on' state	 74	0.317969221431221	0.660658610992004	35	39	7500	9584	1.07700998941875
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	 42	0.891109184963223	1	15	27	7520	9596	0.813252440989667
R-HSA-5635838	Activation of SMO	 16	0.991676465832436	1	3	13	7532	9610	0.426957531519575
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-5637810	Constitutive Signaling by EGFRvIII	 14	0.00915995184693369	0.086701488662296	11	3	7524	9620	1.78915537017727
R-HSA-5637812	Signaling by EGFRvIII in Cancer	 14	0.00915995184693369	0.086701488662296	11	3	7524	9620	1.78915537017727
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	 17	0.00669372185778721	0.0735769588077739	13	4	7522	9619	1.74131699129552
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	  7	0.0312840930957045	0.166822306132956	6	1	7529	9622	1.9518058583752
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	 20	0.218758429843316	0.534520302356683	11	9	7524	9614	1.25240875912409
R-HSA-5652084	Fructose metabolism	  7	0.98256225178826	1	1	6	7534	9617	0.325300976395867
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	 14	0.99636620380658	1	2	12	7533	9611	0.325300976395867
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	 14	0.99636620380658	1	2	12	7533	9611	0.325300976395867
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	 11	0.998277372566188	1	1	10	7534	9613	0.207009712251915
R-HSA-5654687	Downstream signaling of activated FGFR1	 29	0.531992622439841	0.861237493041779	13	16	7522	9607	1.02077202938013
R-HSA-5654688	SHC-mediated cascade:FGFR1	 19	0.9655370800652	1	5	14	7530	9609	0.599238640729228
R-HSA-5654689	PI-3K cascade:FGFR1	 19	0.907721351173715	1	6	13	7529	9610	0.719086368875074
R-HSA-5654693	FRS-mediated FGFR1 signaling	 21	0.77405711321654	1	8	13	7527	9610	0.867469270388978
R-HSA-5654695	PI-3K cascade:FGFR2	 19	0.907721351173715	1	6	13	7529	9610	0.719086368875074
R-HSA-5654696	Downstream signaling of activated FGFR2	 26	0.638652144173975	0.969357319052482	11	15	7524	9608	0.963391353172375
R-HSA-5654699	SHC-mediated cascade:FGFR2	 19	0.9655370800652	1	5	14	7530	9609	0.599238640729228
R-HSA-5654700	FRS-mediated FGFR2 signaling	 21	0.77405711321654	1	8	13	7527	9610	0.867469270388978
R-HSA-5654704	SHC-mediated cascade:FGFR3	 16	0.900431366192639	1	5	11	7530	9612	0.711595885865959
R-HSA-5654706	FRS-mediated FGFR3 signaling	 18	0.572165618600132	0.898458223677397	8	10	7527	9613	1.01204748212047
R-HSA-5654708	Downstream signaling of activated FGFR3	 23	0.430249372091701	0.768584396017023	11	12	7524	9611	1.08905109489051
R-HSA-5654710	PI-3K cascade:FGFR3	 16	0.777226929319867	1	6	10	7529	9613	0.853915063039151
R-HSA-5654712	FRS-mediated FGFR4 signaling	 18	0.74535972595964	1	7	11	7528	9612	0.885541546855415
R-HSA-5654716	Downstream signaling of activated FGFR4	 23	0.596160998217299	0.925802672944902	10	13	7525	9610	0.990046449900464
R-HSA-5654719	SHC-mediated cascade:FGFR4	 16	0.965951718028444	1	4	12	7531	9611	0.569276708692767
R-HSA-5654720	PI-3K cascade:FGFR4	 16	0.900431366192639	1	5	11	7530	9612	0.711595885865959
R-HSA-5654726	Negative regulation of FGFR1 signaling	 30	0.595069670625384	0.925802672944902	13	17	7522	9606	0.986746295067463
R-HSA-5654727	Negative regulation of FGFR2 signaling	 29	0.531992622439841	0.861237493041779	13	16	7522	9607	1.02077202938013
R-HSA-5654732	Negative regulation of FGFR3 signaling	 26	0.332373628504307	0.677975865828461	13	13	7522	9610	1.13855341738553
R-HSA-5654733	Negative regulation of FGFR4 signaling	 26	0.483869864954987	0.822337438820009	12	14	7523	9609	1.05097238527895
R-HSA-5654736	Signaling by FGFR1	 47	0.290860704057125	0.622359716844367	23	24	7512	9599	1.1143288765901
R-HSA-5654738	Signaling by FGFR2	 63	0.0235789353096949	0.146853620139871	36	27	7499	9596	1.30120390558347
R-HSA-5654741	Signaling by FGFR3	 37	0.0798119956941118	0.281746548061106	21	16	7514	9607	1.2924119873025
R-HSA-5654743	Signaling by FGFR4	 36	0.182635741351316	0.465294421424007	19	17	7516	9606	1.20180638501806
R-HSA-5655253	Signaling by FGFR2 in disease	 36	0.283645498800954	0.611722808331805	18	18	7517	9605	1.13855341738553
R-HSA-5655291	Signaling by FGFR4 in disease	 11	0.0524841172200018	0.226078502371331	8	3	7527	9620	1.65607769801532
R-HSA-5655302	Signaling by FGFR1 in disease	 36	0.182635741351316	0.465294421424007	19	17	7516	9606	1.20180638501806
R-HSA-5655332	Signaling by FGFR3 in disease	 20	0.54691392403667	0.867804049431875	9	11	7526	9612	1.02469807564698
R-HSA-5655862	Translesion synthesis by POLK	 16	0.040239810047395	0.190440489911803	11	5	7524	9618	1.56551094890511
R-HSA-5656121	Translesion synthesis by POLI	 16	0.040239810047395	0.190440489911803	11	5	7524	9618	1.56551094890511
R-HSA-5656169	Termination of translesion DNA synthesis	 30	0.311113753296263	0.654395132319145	15	15	7520	9608	1.13855341738553
R-HSA-5658442	Regulation of RAS by GAPs	 58	0.0555605158792274	0.235024021040628	32	26	7503	9597	1.25633480539093
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	 12	0.999034356161789	1	1	11	7534	9612	0.189758902897589
R-HSA-5660526	Response to metal ions	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-5660668	CLEC7A/inflammasome pathway	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-5661231	Metallothioneins bind metals	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-5663084	Diseases of carbohydrate metabolism	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	 36	0.0124581844785199	0.10679563172467	23	13	7512	9610	1.45481825554818
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	 79	0.76516253297057	1	32	47	7503	9576	0.922372388768028
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-5668914	Diseases of metabolism	 36	0.667784492723855	0.975221233468183	15	21	7520	9602	0.948794514487945
R-HSA-5669034	TNFs bind their physiological receptors	 18	0.984949869969325	1	4	14	7531	9609	0.506023741060237
R-HSA-5673000	RAF activation	 25	0.00422113713044163	0.0569644545424945	18	7	7517	9616	1.63951692103517
R-HSA-5674135	MAP2K and MAPK activation	 37	0.464193471310669	0.800629181213145	17	20	7518	9603	1.04623827543536
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	 25	0.154675852577038	0.418457570128669	14	11	7521	9612	1.2751798274718
R-HSA-5674499	Negative feedback regulation of MAPK pathway	  6	0.237586605308932	0.534520302356683	4	2	7531	9621	1.51807122318071
R-HSA-5675221	Negative regulation of MAPK pathway	 39	0.00123306245525088	0.0266772083572533	27	12	7508	9611	1.57645857791843
R-HSA-5675482	Regulation of necroptotic cell death	 17	0.831347184228978	1	6	11	7529	9612	0.803684765213318
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	 49	0.12578912013259	0.367919679701115	26	23	7509	9600	1.20826076947036
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	 15	0.997829761989255	1	2	13	7533	9610	0.303614244636142
R-HSA-5676934	Protein repair	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-5678895	Defective CFTR causes cystic fibrosis	 50	0.0978577945122039	0.32217433314042	27	23	7508	9600	1.22963769077638
R-HSA-5682910	LGI-ADAM interactions	 14	0.0355483893582248	0.178134024614928	10	4	7525	9619	1.62650488197933
R-HSA-5683826	Surfactant metabolism	 20	0.848451711368393	1	7	13	7528	9610	0.796987392169874
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	 14	0.10300264936915	0.333474135606059	9	5	7526	9618	1.4638543937814
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	 31	0.000613010328271534	0.0174069391132104	23	8	7512	9615	1.68946636128176
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-5685942	HDR through Homologous Recombination (HRR)	 52	0.0163063605362238	0.123606453088308	31	21	7504	9602	1.35750599765198
R-HSA-5686938	Regulation of TLR by endogenous ligand	 16	0.998708804297372	1	2	14	7533	9609	0.284638354346384
R-HSA-5687128	MAPK6/MAPK4 signaling	 77	0.00369742155581226	0.0511746481943655	46	31	7489	9592	1.36034953765544
R-HSA-5687613	Diseases associated with surfactant metabolism	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-5689603	UCH proteinases	 76	0.0303683371474497	0.166822306132956	42	34	7493	9589	1.25840114553138
R-HSA-5689877	Josephin domain DUBs	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-5689896	Ovarian tumor domain proteases	 32	0.301436262292754	0.638969868592572	16	16	7519	9607	1.13855341738553
R-HSA-5689901	Metalloprotease DUBs	 22	0.111580283873068	0.341462890835091	13	9	7522	9614	1.34556312963745
R-HSA-5690714	CD22 mediated BCR regulation	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-5693537	Resolution of D-Loop Structures	 25	0.154675852577038	0.418457570128669	14	11	7521	9612	1.2751798274718
R-HSA-5693548	Sensing of DNA Double Strand Breaks	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	 20	0.218758429843316	0.534520302356683	11	9	7524	9614	1.25240875912409
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	 56	0.613806819950634	0.942138170712516	24	32	7511	9591	0.975902929187601
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	 98	0.23927345440047	0.534520302356683	47	51	7488	9572	1.09208184932898
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	 25	0.154675852577038	0.418457570128669	14	11	7521	9612	1.2751798274718
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	 50	0.549612004708828	0.870563969170291	22	28	7513	9595	1.00192700729927
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	 33	0.00246315056897843	0.0409423686038731	23	10	7512	9613	1.58707446059802
R-HSA-5693606	DNA Double Strand Break Response	 56	0.613806819950634	0.942138170712516	24	32	7511	9591	0.975902929187601
R-HSA-5693607	Processing of DNA double-strand break ends	 72	0.245819941053375	0.545688240481677	35	37	7500	9586	1.10692693356927
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	 31	0.000613010328271534	0.0174069391132104	23	8	7512	9615	1.68946636128176
R-HSA-5694530	Cargo concentration in the ER	 30	0.110778333389092	0.341462890835091	17	13	7518	9610	1.29036053970361
R-HSA-5696394	DNA Damage Recognition in GG-NER	 36	0.00492895451930139	0.0603347853218756	24	12	7511	9611	1.51807122318071
R-HSA-5696395	Formation of Incision Complex in GG-NER	 40	0.000234495248927409	0.00954299497385471	29	11	7506	9612	1.65090245520902
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	 23	0.276729212182729	0.598701454293746	12	11	7523	9612	1.18805573988056
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	 79	6.90608364034624e-05	0.00546372159427944	52	27	7483	9596	1.49885513174804
R-HSA-5696400	Dual Incision in GG-NER	 38	0.00197789824097521	0.0345539052475334	26	12	7509	9611	1.55802046589599
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	 41	0.99973365345577	1	8	33	7527	9590	0.444313528735818
R-HSA-611105	Respiratory electron transport	 84	2.46316072499313e-08	2.25575880819798e-05	62	22	7473	9601	1.68072171137865
R-HSA-622312	Inflammasomes	 16	0.106693542283681	0.338982046929272	10	6	7525	9617	1.42319177173192
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	  8	1	1	0	8	7535	9615	0
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	  8	1	1	0	8	7535	9615	0
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	  5	1	1	0	5	7535	9618	0
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	  5	1	1	0	5	7535	9618	0
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	  5	1	1	0	5	7535	9618	0
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	  8	1	1	0	8	7535	9615	0
R-HSA-674695	RNA Polymerase II Pre-transcription Events	 70	0.0827331286746427	0.288402185124138	37	33	7498	9590	1.20361361266471
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	 47	1.15561711323349e-06	0.000317966612923193	37	10	7498	9613	1.79261601886233
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	 71	5.49337042659111e-06	0.000831940432382631	50	21	7485	9602	1.60359636251484
R-HSA-6782135	Dual incision in TC-NER	 58	3.31000447117588e-05	0.00341969527806746	41	17	7494	9606	1.60967896940713
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	 57	0.00015957055914997	0.00749981628004861	39	18	7496	9605	1.55802046589599
R-HSA-6782315	tRNA modification in the nucleus and cytosol	 38	0.0290119642964595	0.166406823344362	23	15	7512	9608	1.37824887367723
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-6783310	Fanconi Anemia Pathway	 33	0.080203712874328	0.281746548061106	19	14	7516	9609	1.3110615109288
R-HSA-6783589	Interleukin-6 family signaling	 24	0.503111057915753	0.840368102866631	11	13	7524	9610	1.04367396593674
R-HSA-6783783	Interleukin-10 signaling	 36	0.999473595272261	1	7	29	7528	9594	0.442770773427708
R-HSA-6784531	tRNA processing in the nucleus	 54	0.0165764540908581	0.123606453088308	32	22	7503	9601	1.3493966428273
R-HSA-6785631	ERBB2 Regulates Cell Motility	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-6785807	Interleukin-4 and 13 signaling	 95	0.998663504277966	1	28	67	7507	9556	0.671147277616736
R-HSA-6787450	tRNA modification in the mitochondrion	  7	0.0312840930957045	0.166822306132956	6	1	7529	9622	1.9518058583752
R-HSA-6787639	GDP-fucose biosynthesis	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	 17	0.831347184228978	1	6	11	7529	9612	0.803684765213318
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	 35	0.348170553356938	0.689762302653353	17	18	7518	9605	1.10602331974595
R-HSA-6790901	rRNA modification in the nucleus and cytosol	 52	0.0163063605362238	0.123606453088308	31	21	7504	9602	1.35750599765198
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	 47	0.889253506579022	1	17	30	7518	9593	0.823634387044854
R-HSA-6793080	rRNA modification in the mitochondrion	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	 53	0.0742628485923998	0.279613985169726	29	24	7506	9599	1.24596411713889
R-HSA-6794362	Protein-protein interactions at synapses	 65	0.0412938895118266	0.193414334723779	36	29	7499	9594	1.26116686233475
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	 52	0.0014531340043229	0.0294752474269789	34	18	7501	9605	1.48887754581185
R-HSA-6798163	Choline catabolism	  6	0.237586605308932	0.534520302356683	4	2	7531	9621	1.51807122318071
R-HSA-6799198	Complex I biogenesis	 47	0.000238049764571578	0.00954299497385471	33	14	7502	9609	1.59881969249884
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	 37	0.337327056432158	0.677975865828461	18	19	7517	9604	1.10778170340214
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	 33	0.359663274789318	0.699620822073174	16	17	7519	9606	1.10405179867688
R-HSA-6802949	Signaling by RAS mutants	 47	0.199612497796341	0.502186080663988	24	23	7511	9600	1.16277795818097
R-HSA-6802952	Signaling by BRAF and RAF fusions	 56	0.0932565832750037	0.311540987754485	30	26	7505	9597	1.2198786614845
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	 37	0.337327056432158	0.677975865828461	18	19	7517	9604	1.10778170340214
R-HSA-6802957	Oncogenic MAPK signaling	 69	0.0664532239408342	0.260275127101601	37	32	7498	9591	1.22105728821057
R-HSA-6803157	Antimicrobial peptides	 38	0.999949363425207	1	6	32	7529	9591	0.359543184437537
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	 20	0.848451711368393	1	7	13	7528	9610	0.796987392169874
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	 13	0.89345159104885	1	4	9	7531	9614	0.700648256852636
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	 11	0.788442254625565	1	4	7	7531	9616	0.828038849007661
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	 12	0.999034356161789	1	1	11	7534	9612	0.189758902897589
R-HSA-6803529	FGFR2 alternative splicing	 23	0.0116385738253352	0.103682196888444	16	7	7519	9616	1.58407431984074
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	 17	0.929216442010831	1	5	12	7530	9611	0.669737304344432
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	 20	0.54691392403667	0.867804049431875	9	11	7526	9612	1.02469807564698
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	 13	0.967997587249324	1	3	10	7532	9613	0.525486192639477
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	 82	0.00989667056862485	0.0917630067009229	47	35	7488	9588	1.30517099066147
R-HSA-6804757	Regulation of TP53 Degradation	 33	0.080203712874328	0.281746548061106	19	14	7516	9609	1.3110615109288
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	 30	0.110778333389092	0.341462890835091	17	13	7518	9610	1.29036053970361
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	 12	0.950794665049215	1	3	9	7532	9614	0.569276708692767
R-HSA-6804760	Regulation of TP53 Activity through Methylation	 18	0.223444995996434	0.534520302356683	10	8	7525	9615	1.26505935265059
R-HSA-6805567	Keratinization	 78	0.999999996810016	1	11	67	7524	9556	0.321130451057458
R-HSA-6806003	Regulation of TP53 Expression and Degradation	 34	0.10889972412387	0.341462890835091	19	15	7516	9608	1.27250087825442
R-HSA-6806667	Metabolism of fat-soluble vitamins	 43	0.99596905719506	1	11	32	7524	9591	0.58251570191818
R-HSA-6806834	Signaling by MET	 72	0.00242682915811886	0.0408366437347656	44	28	7491	9595	1.39156528791565
R-HSA-6807004	Negative regulation of MET activity	 20	0.0167771047845465	0.123606453088308	14	6	7521	9617	1.59397478433975
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	 64	0.00448708342979222	0.0588066799500653	39	25	7496	9598	1.38761197743862
R-HSA-6807878	COPI-mediated anterograde transport	 81	0.000921862123996846	0.0224374656251375	50	31	7485	9592	1.4056215029451
R-HSA-6809371	Formation of the cornified envelope	 64	0.999999939085912	1	9	55	7526	9568	0.320218148639682
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	 76	0.234042416679513	0.534520302356683	37	39	7498	9584	1.10859148534907
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	 38	0.000190466912840053	0.0083681339516885	28	10	7507	9613	1.67786819404184
R-HSA-6811438	Intra-Golgi traffic	 38	0.000651128013985267	0.0181119894502432	27	11	7508	9612	1.61794432996892
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	 45	0.00172767722903793	0.0319742557293318	30	15	7505	9608	1.51807122318071
R-HSA-6811555	PI5P Regulates TP53 Acetylation	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	 74	0.67893834981146	0.986559670355032	31	43	7504	9580	0.953923133485177
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	 36	0.057955697917377	0.238233737260008	21	15	7514	9608	1.32831232028312
R-HSA-6814848	Glycerophospholipid catabolism	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-68616	Assembly of the ORC complex at the origin of replication	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-68689	CDC6 association with the ORC:origin complex	  8	0.240004713897498	0.534520302356683	5	3	7530	9620	1.42319177173192
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	 46	0.0580068850563216	0.238233737260008	26	20	7509	9603	1.2870603848706
R-HSA-68867	Assembly of the pre-replicative complex	 54	0.149309343976591	0.418392979533487	28	26	7507	9597	1.18072206247389
R-HSA-68874	M/G1 Transition	 69	0.383820570906169	0.705228057906781	32	37	7503	9586	1.0560495465605
R-HSA-68877	Mitotic Prometaphase	 94	0.250491692860036	0.555154759948341	45	49	7490	9574	1.09010433579466
R-HSA-68884	Mitotic Telophase/Cytokinesis	 11	0.155313269279354	0.418457570128669	7	4	7528	9619	1.44906798576341
R-HSA-68911	G2 Phase	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-68949	Orc1 removal from chromatin	 58	0.142914953921987	0.404975222860016	30	28	7505	9595	1.177813880054
R-HSA-68952	DNA replication initiation	  7	1	1	0	7	7535	9616	0
R-HSA-68962	Activation of the pre-replicative complex	 27	0.698330777455614	1	11	16	7524	9607	0.927710191943769
R-HSA-69002	DNA Replication Pre-Initiation	 69	0.383820570906169	0.705228057906781	32	37	7503	9586	1.0560495465605
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	 40	0.174536647959765	0.448010265855292	21	19	7514	9604	1.19548108825481
R-HSA-69052	Switching of origins to a post-replicative state	 58	0.142914953921987	0.404975222860016	30	28	7505	9595	1.177813880054
R-HSA-69091	Polymerase switching	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-69109	Leading Strand Synthesis	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-69166	Removal of the Flap Intermediate	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-69183	Processive synthesis on the lagging strand	 13	0.747445650914158	1	5	8	7530	9615	0.875810321065796
R-HSA-69186	Lagging Strand Synthesis	 18	0.223444995996434	0.534520302356683	10	8	7525	9615	1.26505935265059
R-HSA-69190	DNA strand elongation	 29	0.384923619130613	0.705228057906781	14	15	7521	9608	1.09929295471707
R-HSA-69202	Cyclin E associated events during G1/S transition 	 59	0.114190586487504	0.347414663800152	31	28	7504	9595	1.19644596403226
R-HSA-69205	G1/S-Specific Transcription	 13	0.747445650914158	1	5	8	7530	9615	0.875810321065796
R-HSA-69206	G1/S Transition	100	0.0920179245036411	0.30815830736723	51	49	7484	9574	1.16132448573324
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	 40	0.174536647959765	0.448010265855292	21	19	7514	9604	1.19548108825481
R-HSA-69231	Cyclin D associated events in G1	 34	0.0274246860545291	0.163452700710687	21	13	7514	9610	1.40644833912331
R-HSA-69236	G1 Phase	 34	0.0274246860545291	0.163452700710687	21	13	7514	9610	1.40644833912331
R-HSA-69239	Synthesis of DNA	 84	0.212665224697145	0.527983062408395	41	43	7494	9580	1.11144500268588
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	 18	0.223444995996434	0.534520302356683	10	8	7525	9615	1.26505935265059
R-HSA-69298	Association of licensing factors with the pre-replicative complex	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-69300	Removal of licensing factors from origins	 59	0.172629816785244	0.445633409617969	30	29	7505	9594	1.15785093293444
R-HSA-69304	Regulation of DNA replication	 61	0.241025955284202	0.535919049025069	30	31	7505	9592	1.11988860726446
R-HSA-69306	DNA Replication	 90	0.262383240395254	0.578686661260083	43	47	7492	9576	1.08795104327951
R-HSA-69416	Dimerization of procaspase-8	 11	0.983424571687017	1	2	9	7533	9614	0.414019424503831
R-HSA-69473	G2/M DNA damage checkpoint	 70	0.125596491035921	0.367919679701115	36	34	7499	9589	1.17108351502512
R-HSA-69478	G2/M DNA replication checkpoint	  5	1	1	0	5	7535	9618	0
R-HSA-69541	Stabilization of p53	 45	0.0775774407637702	0.281746548061106	25	20	7510	9603	1.26505935265059
R-HSA-69563	p53-Dependent G1 DNA Damage Response	 54	0.149309343976591	0.418392979533487	28	26	7507	9597	1.18072206247389
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	 54	0.149309343976591	0.418392979533487	28	26	7507	9597	1.18072206247389
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	 41	0.135622476521258	0.389165127365209	22	19	7513	9604	1.2218622040235
R-HSA-69610	p53-Independent DNA Damage Response	 41	0.135622476521258	0.389165127365209	22	19	7513	9604	1.2218622040235
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	 41	0.135622476521258	0.389165127365209	22	19	7513	9604	1.2218622040235
R-HSA-69615	G1/S DNA Damage Checkpoints	 54	0.149309343976591	0.418392979533487	28	26	7507	9597	1.18072206247389
R-HSA-69618	Mitotic Spindle Checkpoint	 18	0.109160004132176	0.341462890835091	11	7	7524	9616	1.39156528791565
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	 58	0.0917230119595428	0.307927254435608	31	27	7504	9596	1.21707434272247
R-HSA-70153	Glucose transport	 41	0.215396527970199	0.530895963152587	21	20	7514	9603	1.16632301293152
R-HSA-70171	Glycolysis	 30	0.0561505295919752	0.23548668256573	18	12	7517	9611	1.36626410086264
R-HSA-70221	Glycogen breakdown (glycogenolysis)	 17	0.678006461986498	0.986256998599357	7	10	7528	9613	0.937632226082205
R-HSA-70263	Gluconeogenesis	 28	0.111435066561028	0.341462890835091	16	12	7519	9611	1.30120390558347
R-HSA-70268	Pyruvate metabolism	 24	0.0070585856845287	0.0763559705397827	17	7	7518	9616	1.61295067462951
R-HSA-70326	Glucose metabolism	 74	0.0306035818229873	0.166822306132956	41	33	7494	9590	1.26164027331911
R-HSA-70350	Fructose catabolism	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-70370	Galactose catabolism	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	 27	0.0144204055057082	0.116404733529945	18	9	7517	9614	1.51807122318071
R-HSA-70635	Urea cycle	  6	0.968899630100056	1	1	5	7534	9618	0.379517805795178
R-HSA-70895	Branched-chain amino acid catabolism	 20	0.00110383562402056	0.0252409637678795	16	4	7519	9619	1.82168546781685
R-HSA-70921	Histidine catabolism	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-71032	Propionyl-CoA catabolism	  5	0.0163214830538156	0.123606453088308	5	0	7530	9623	2.27710683477107
R-HSA-71064	Lysine catabolism	 11	0.0524841172200018	0.226078502371331	8	3	7527	9620	1.65607769801532
R-HSA-71182	Phenylalanine and tyrosine catabolism	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-71240	Tryptophan catabolism	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-71288	Creatine metabolism	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	  9	0.149491842283792	0.418392979533487	6	3	7529	9620	1.51807122318071
R-HSA-71384	Ethanol oxidation	 10	0.710521535256374	1	4	6	7531	9617	0.910842733908427
R-HSA-71403	Citric acid cycle (TCA cycle)	 18	0.000100214996226695	0.00546372159427944	16	2	7519	9621	2.02409496424095
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	 44	2.757970815006e-05	0.00316077575572012	33	11	7502	9612	1.7078301260783
R-HSA-72086	mRNA Capping	 24	0.00200275753085483	0.0345539052475334	18	6	7517	9617	1.7078301260783
R-HSA-72165	mRNA Splicing - Minor Pathway	 47	0.0768208729420024	0.281746548061106	26	21	7509	9602	1.25967612136272
R-HSA-72187	mRNA 3'-end processing	 50	0.000170327210129829	0.00773853291356525	35	15	7500	9608	1.59397478433975
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	 71	0.000309842143864606	0.0117309678357627	46	25	7489	9598	1.47530865351365
R-HSA-72306	tRNA processing	 97	0.000577390133127531	0.0174069391132104	59	38	7476	9585	1.38504436341745
R-HSA-72613	Eukaryotic Translation Initiation	 73	0.456594244389679	0.797869173209144	33	40	7502	9583	1.02937706229377
R-HSA-72649	Translation initiation complex formation	 37	0.337327056432158	0.677975865828461	18	19	7517	9604	1.10778170340214
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	 38	0.393035350752387	0.713325143908794	18	20	7517	9603	1.07862955331261
R-HSA-72689	Formation of a pool of free 40S subunits	 56	0.401477742584157	0.726368009645695	26	30	7509	9593	1.05722817328657
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	 31	0.371883107672884	0.701074240329379	15	16	7520	9607	1.10182588779245
R-HSA-72702	Ribosomal scanning and start codon recognition	 37	0.337327056432158	0.677975865828461	18	19	7517	9604	1.10778170340214
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	 66	0.545854416271612	0.867804049431875	29	37	7506	9586	1.00054694255092
R-HSA-72731	Recycling of eIF2:GDP	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-72737	Cap-dependent Translation Initiation	 73	0.456594244389679	0.797869173209144	33	40	7502	9583	1.02937706229377
R-HSA-72764	Eukaryotic Translation Termination	 50	0.436373690085352	0.775459373645808	23	27	7512	9596	1.04746914399469
R-HSA-727802	Transport of nucleotide sugars	  8	0.0786434095133959	0.281746548061106	6	2	7529	9621	1.7078301260783
R-HSA-73614	Pyrimidine salvage reactions	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-73621	Pyrimidine catabolism	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-73728	RNA Polymerase I Promoter Opening	 29	0.999998785182341	1	2	27	7533	9596	0.157041850673867
R-HSA-73762	RNA Polymerase I Transcription Initiation	 45	0.00438391585920235	0.0585811501577726	29	16	7506	9607	1.46746884907469
R-HSA-73772	RNA Polymerase I Promoter Escape	 28	0.00299100710761665	0.0474039847404824	20	8	7515	9615	1.62650488197933
R-HSA-73776	RNA Polymerase II Promoter Escape	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-73777	RNA Polymerase I Chain Elongation	 54	0.727069011337215	1	22	32	7513	9591	0.927710191943769
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-73780	RNA Polymerase III Chain Elongation	 17	0.0243278765164166	0.148694599515138	12	5	7523	9618	1.60736953042664
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	 12	0.848526686392022	1	4	8	7531	9615	0.759035611590356
R-HSA-73847	Purine metabolism	 32	0.434042088890645	0.772322933626566	15	17	7520	9606	1.06739382879894
R-HSA-73848	Pyrimidine metabolism	 22	0.914849009601046	1	7	15	7528	9608	0.724533992881704
R-HSA-73854	RNA Polymerase I Promoter Clearance	 73	0.6419790137446	0.973323020838587	31	42	7504	9581	0.966990573669906
R-HSA-73856	RNA Polymerase II Transcription Termination	 58	0.000733786739869156	0.0196108103223855	38	20	7497	9603	1.49189758140173
R-HSA-73863	RNA Polymerase I Transcription Termination	 29	0.00178286385578079	0.0319742557293318	21	8	7514	9615	1.6489394320756
R-HSA-73864	RNA Polymerase I Transcription	 75	0.538639438866425	0.86372418255875	33	42	7502	9581	1.00192700729927
R-HSA-73884	Base Excision Repair	 36	0.00492895451930139	0.0603347853218756	24	12	7511	9611	1.51807122318071
R-HSA-73886	Chromosome Maintenance	 75	0.993284145967397	1	23	52	7512	9571	0.698312762663128
R-HSA-73887	Death Receptor Signalling	 45	0.130660049734355	0.37891414422963	24	21	7511	9602	1.21445697854457
R-HSA-73893	DNA Damage Bypass	 45	0.130660049734355	0.37891414422963	24	21	7511	9602	1.21445697854457
R-HSA-73923	Lipid digestion, mobilization, and transport	 83	0.907164542548373	1	31	52	7504	9571	0.850485685275941
R-HSA-73928	Depyrimidination	  8	0.0154976542898073	0.120704587411471	7	1	7528	9622	1.99246848042468
R-HSA-73929	Base-Excision Repair, AP Site Formation	 10	0.00366572103319282	0.0511746481943655	9	1	7526	9622	2.04939615129396
R-HSA-73933	Resolution of Abasic Sites (AP sites)	 36	0.00492895451930139	0.0603347853218756	24	12	7511	9611	1.51807122318071
R-HSA-73942	DNA Damage Reversal	  8	0.928935406156623	1	2	6	7533	9617	0.569276708692767
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-73980	RNA Polymerase III Transcription Termination	 22	0.00153539440008474	0.0294752474269789	17	5	7518	9618	1.75958255414128
R-HSA-74158	RNA Polymerase III Transcription	 39	0.000392490484533876	0.0130479153760896	28	11	7507	9612	1.63484593265615
R-HSA-74182	Ketone body metabolism	  8	0.0786434095133959	0.281746548061106	6	2	7529	9621	1.7078301260783
R-HSA-74217	Purine salvage	 13	0.158412465982348	0.418457570128669	8	5	7527	9618	1.40129651370527
R-HSA-74259	Purine catabolism	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-74713	IRS activation	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-74749	Signal attenuation	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	 39	0.000392490484533876	0.0130479153760896	28	11	7507	9612	1.63484593265615
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	 27	0.0792385101929455	0.281746548061106	16	11	7519	9612	1.3493966428273
R-HSA-75072	mRNA Editing	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	 42	8.16510260228127e-05	0.00546372159427944	31	11	7504	9612	1.68072171137865
R-HSA-75109	Triglyceride Biosynthesis	 63	2.78278129630532e-05	0.00316077575572012	44	19	7491	9604	1.59036032904646
R-HSA-75153	Apoptotic execution  phase	 45	0.750568292860929	1	18	27	7517	9596	0.910842733908427
R-HSA-75157	FasL/ CD95L signaling	  5	1	1	0	5	7535	9618	0
R-HSA-75158	TRAIL  signaling	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-75205	Dissolution of Fibrin Clot	 10	0.996927117940809	1	1	9	7534	9614	0.227710683477107
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	 40	0.174536647959765	0.448010265855292	21	19	7514	9604	1.19548108825481
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	 23	0.032510408078718	0.169128573325544	15	8	7520	9615	1.4850696748507
R-HSA-75892	Platelet Adhesion to exposed collagen	 10	0.887922556996002	1	3	7	7532	9616	0.683132050431321
R-HSA-75893	TNF signaling	 38	0.0582038404310951	0.238233737260008	22	16	7513	9607	1.3183250096043
R-HSA-75953	RNA Polymerase II Transcription Initiation	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-75955	RNA Polymerase II Transcription Elongation	 49	0.042845669616077	0.195706844630345	28	21	7507	9602	1.30120390558347
R-HSA-76009	Platelet Aggregation (Plug Formation)	 31	0.970257013751255	1	9	22	7526	9601	0.661095532675471
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	 40	0.0296322323839304	0.166406823344362	24	16	7511	9607	1.36626410086264
R-HSA-76046	RNA Polymerase III Transcription Initiation	 34	0.00446465368385776	0.0588066799500653	23	11	7512	9612	1.54039579999219
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	 26	0.00811200895484969	0.0813086996479031	18	8	7517	9615	1.57645857791843
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	 25	0.0130881638619638	0.109442744440838	17	8	7518	9615	1.54843264764433
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	 27	0.00495781067942045	0.0603347853218756	19	8	7516	9615	1.60240851335742
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	 22	0.00153539440008474	0.0294752474269789	17	5	7518	9618	1.75958255414128
R-HSA-77111	Synthesis of Ketone Bodies	  7	0.139153898657434	0.395964016430236	5	2	7530	9621	1.62650488197933
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	 20	0.218758429843316	0.534520302356683	11	9	7524	9614	1.25240875912409
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-77387	Insulin receptor recycling	 21	0.000591772676017973	0.0174069391132104	17	4	7518	9619	1.84337219957658
R-HSA-774815	Nucleosome assembly	 41	0.99973365345577	1	8	33	7527	9590	0.444313528735818
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	 10	0.710521535256374	1	4	6	7531	9617	0.910842733908427
R-HSA-77595	Processing of Intronless Pre-mRNAs	 19	0.0274619724598293	0.163452700710687	13	6	7522	9617	1.55802046589599
R-HSA-804914	Transport of fatty acids	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	  6	0.822710430352035	1	2	4	7533	9619	0.759035611590356
R-HSA-844456	The NLRP3 inflammasome	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-877300	Interferon gamma signaling	 71	0.96839234015594	1	24	47	7511	9576	0.769726254007122
R-HSA-877312	Regulation of IFNG signaling	 13	0.326673412817859	0.671374446718672	7	6	7528	9617	1.22613444949211
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-879518	Transport of organic anions	  9	0.834702250474114	1	3	6	7532	9617	0.759035611590356
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-8848021	Signaling by PTK6	 60	0.0901955853118995	0.303547117975602	32	28	7503	9595	1.21445697854457
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	  8	0.497655714457693	0.834323171962897	4	4	7531	9619	1.13855341738553
R-HSA-8849470	PTK6 Regulates Cell Cycle	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	 26	0.0224875675754014	0.146506213373903	17	9	7518	9614	1.48887754581185
R-HSA-8849473	PTK6 Expression	  5	0.727292556794355	1	2	3	7533	9620	0.910842733908427
R-HSA-8849932	SALM protein interactions at the synapses	 18	0.109160004132176	0.341462890835091	11	7	7524	9616	1.39156528791565
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-8851680	Butyrophilin (BTN) family interactions	  9	0.613263643292143	0.942138170712516	4	5	7531	9618	1.01204748212047
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 16	0.106693542283681	0.338982046929272	10	6	7525	9617	1.42319177173192
R-HSA-8851805	MET activates RAS signaling	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-8851907	MET activates PI3K/AKT signaling	  6	0.536456809678995	0.861237493041779	3	3	7532	9620	1.13855341738553
R-HSA-8852135	Protein ubiquitination	 51	0.190003577324441	0.483162081890324	26	25	7509	9598	1.16087799419702
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	 61	0.327764602388814	0.671794215121734	29	32	7506	9591	1.08255898702231
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	 10	0.0232231889757075	0.146506213373903	8	2	7527	9621	1.82168546781685
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	 20	0.54691392403667	0.867804049431875	9	11	7526	9612	1.02469807564698
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	 45	0.0775774407637702	0.281746548061106	25	20	7510	9603	1.26505935265059
R-HSA-8854214	TBC/RABGAPs	 40	0.00579712013772337	0.067533972202709	26	14	7509	9609	1.48011944260119
R-HSA-8854518	AURKA Activation by TPX2	 67	0.00324567033353523	0.0497061647708823	41	26	7494	9597	1.39345343620319
R-HSA-8854691	Interleukin-19, 20, 22, 24	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-8855121	VLDL interactions	 20	0.110715314015332	0.341462890835091	12	8	7523	9615	1.36626410086264
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	 95	1.16642191094348e-06	0.000317966612923193	65	30	7470	9593	1.55802046589599
R-HSA-8857538	PTK6 promotes HIF1A stabilization	  6	0.237586605308932	0.534520302356683	4	2	7531	9621	1.51807122318071
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 19	0.0726693044916316	0.275900451315025	12	7	7523	9616	1.43817273775015
R-HSA-8863678	Neurodegenerative Diseases	 19	0.0726693044916316	0.275900451315025	12	7	7523	9616	1.43817273775015
R-HSA-8863795	Downregulation of ERBB2 signaling	 25	0.0130881638619638	0.109442744440838	17	8	7518	9615	1.54843264764433
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	 30	0.959670462808185	1	9	21	7526	9602	0.683132050431321
R-HSA-8865999	MET activates PTPN11	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-8866376	Reelin signalling pathway	  5	0.120598226797586	0.356562653199804	4	1	7531	9622	1.82168546781685
R-HSA-8866427	VLDLR internalisation and degradation	 12	0.029911718062633	0.166406823344362	9	3	7526	9620	1.7078301260783
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	 26	0.0224875675754014	0.146506213373903	17	9	7518	9614	1.48887754581185
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	 34	0.687479941360412	0.995874488472821	14	20	7521	9603	0.937632226082205
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	  8	0.990223229735637	1	1	7	7534	9616	0.284638354346384
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	 10	0.710521535256374	1	4	6	7531	9617	0.910842733908427
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	  9	0.353145803414631	0.693570216216343	5	4	7530	9619	1.26505935265059
R-HSA-8868766	rRNA processing in the mitochondrion	  8	0.760889381413457	1	3	5	7532	9618	0.853915063039151
R-HSA-8873719	RAB geranylgeranylation	 55	0.00103201494597931	0.0242523512305138	36	19	7499	9604	1.49046992821379
R-HSA-8874081	MET activates PTK2 signaling	 28	0.616183150302867	0.942601160339851	12	16	7523	9607	0.975902929187601
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	 14	0.00915995184693369	0.086701488662296	11	3	7524	9620	1.78915537017727
R-HSA-8875513	MET interacts with TNS proteins	  5	0.944534763475386	1	1	4	7534	9619	0.455421366954214
R-HSA-8875555	MET activates RAP1 and RAC1	 10	0.238914801483466	0.534520302356683	6	4	7529	9619	1.36626410086264
R-HSA-8875656	MET receptor recycling	 10	0.0232231889757075	0.146506213373903	8	2	7527	9621	1.82168546781685
R-HSA-8875878	MET promotes cell motility	 38	0.275428951631903	0.59778608451319	19	19	7516	9604	1.13855341738553
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	 82	0.00535188108702457	0.063691141302213	48	34	7487	9589	1.33294058620745
R-HSA-8876384	Listeria monocytogenes entry into host cells	 18	0.0441173053136512	0.198455073077579	12	6	7523	9617	1.51807122318071
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-8876725	Protein methylation	 17	0.304560107814341	0.643589809226275	9	8	7526	9615	1.20552714781998
R-HSA-888590	GABA synthesis, release, reuptake and degradation	 18	0.000100214996226695	0.00546372159427944	16	2	7519	9621	2.02409496424095
R-HSA-8937144	Aryl hydrocarbon receptor signalling	  7	0.886923899970831	1	2	5	7533	9618	0.650601952791734
R-HSA-8948216	Collagen chain trimerization	 35	0.479645642119833	0.818219036557362	16	19	7519	9604	1.04096312446677
R-HSA-901032	ER Quality Control Compartment (ERQC)	 19	0.00203742443283634	0.0347126187744492	15	4	7520	9619	1.79771592218769
R-HSA-901042	Calnexin/calreticulin cycle	 24	8.63857507001382e-05	0.00546372159427944	20	4	7515	9619	1.89758902897589
R-HSA-909733	Interferon alpha/beta signaling	 52	0.998542492192185	1	13	39	7522	9584	0.569276708692767
R-HSA-912446	Meiotic recombination	 43	0.989818728560906	1	12	31	7523	9592	0.635471674819833
R-HSA-912631	Regulation of signaling by CBL	 20	0.370598850724014	0.699620822073174	10	10	7525	9613	1.13855341738553
R-HSA-912694	Regulation of IFNA signaling	 14	0.421054604169104	0.754135907335728	7	7	7528	9616	1.13855341738553
R-HSA-913709	O-linked glycosylation of mucins	 55	0.966396941487158	1	18	37	7517	9586	0.745234964106895
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	 25	0.268514320830175	0.587642089696079	13	12	7522	9611	1.18409555408096
R-HSA-917937	Iron uptake and transport	 35	0.000911016543087641	0.0224374656251375	25	10	7510	9613	1.62650488197933
R-HSA-917977	Transferrin endocytosis and recycling	 24	8.63857507001382e-05	0.00546372159427944	20	4	7515	9619	1.89758902897589
R-HSA-918233	TRAF3-dependent IRF activation pathway	 13	0.747445650914158	1	5	8	7530	9615	0.875810321065796
R-HSA-927802	Nonsense-Mediated Decay (NMD)	 72	0.177715871231127	0.454459160390294	36	36	7499	9587	1.13855341738553
R-HSA-933541	TRAF6 mediated IRF7 activation	 21	0.88564901044432	1	7	14	7528	9609	0.759035611590356
R-HSA-933542	TRAF6 mediated NF-kB activation	 22	0.823077583679908	1	8	14	7527	9609	0.828038849007661
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	 11	0.788442254625565	1	4	7	7531	9616	0.828038849007661
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	 32	0.191149954962977	0.485172045837129	17	15	7518	9608	1.20971300597213
R-HSA-936837	Ion transport by P-type ATPases	 52	0.0963283006821056	0.321015828434499	28	24	7507	9599	1.22613444949211
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	 15	0.315178550035463	0.657868857118432	8	7	7527	9616	1.21445697854457
R-HSA-937039	IRAK1 recruits IKK complex	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-937041	IKK complex recruitment mediated by RIP1	 20	0.370598850724014	0.699620822073174	10	10	7525	9613	1.13855341738553
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	  9	0.149491842283792	0.418392979533487	6	3	7529	9620	1.51807122318071
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling 	 92	0.0280825603239699	0.164985041903323	50	42	7485	9581	1.23755806237558
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	 15	0.315178550035463	0.657868857118432	8	7	7527	9616	1.21445697854457
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	  5	0.387021707493963	0.705228057906781	3	2	7532	9621	1.36626410086264
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	 12	0.668273391092651	0.975221233468183	5	7	7530	9616	0.948794514487945
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	 84	0.0730125202517804	0.276433514175491	44	40	7491	9583	1.19277024678485
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	 11	0.339236640128401	0.677975865828461	6	5	7529	9618	1.24205827351149
R-HSA-975155	MyD88 dependent cascade initiated on endosome	 86	0.0717042131468488	0.275900451315025	45	41	7490	9582	1.19150939028719
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	 14	0.421054604169104	0.754135907335728	7	7	7528	9616	1.13855341738553
R-HSA-975298	Ligand-gated ion channel transport	 15	0.315178550035463	0.657868857118432	8	7	7527	9616	1.21445697854457
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	 25	0.413948525054673	0.745326076155244	12	13	7523	9610	1.09301128069011
R-HSA-975577	N-Glycan antennae elongation	 14	0.421054604169104	0.754135907335728	7	7	7528	9616	1.13855341738553
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	 10	0.467376805345795	0.800629181213145	5	5	7530	9618	1.13855341738553
R-HSA-975634	Retinoid metabolism and transport	 38	0.992041769354963	1	10	28	7525	9595	0.599238640729228
R-HSA-975871	MyD88 cascade initiated on plasma membrane	 79	0.038516617912818	0.188165412957602	43	36	7492	9587	1.23943789740704
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	 52	0.31934345456082	0.662504000862096	25	27	7510	9596	1.09476290133224
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	 72	0.177715871231127	0.454459160390294	36	36	7499	9587	1.13855341738553
R-HSA-977068	Termination of O-glycan biosynthesis	 18	0.996730192821395	1	3	15	7532	9608	0.379517805795178
R-HSA-977225	Amyloid fiber formation	 58	0.996552274383618	1	16	42	7519	9581	0.628167402695467
R-HSA-977347	Serine biosynthesis	  7	0.662176756305045	0.975221233468183	3	4	7532	9619	0.975902929187601
R-HSA-977441	GABA A receptor activation	 10	0.0898765361506754	0.303222076171709	7	3	7528	9620	1.59397478433975
R-HSA-977443	GABA receptor activation	 46	0.163152044315969	0.426008115713918	24	22	7511	9601	1.18805573988056
R-HSA-977444	GABA B receptor activation	 35	0.348170553356938	0.689762302653353	17	18	7518	9605	1.10602331974595
R-HSA-977606	Regulation of Complement cascade	 18	0.95032241456744	1	5	13	7530	9610	0.632529676325297
R-HSA-982772	Growth hormone receptor signaling	 21	0.285428937903023	0.612660854113103	11	10	7524	9613	1.19277024678485
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	 23	0.863393602256841	1	8	15	7527	9608	0.792037159920372
R-HSA-983189	Kinesins	 40	0.630672486429095	0.96248382637886	17	23	7518	9600	0.967770404777704
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	 38	0.275428951631903	0.59778608451319	19	19	7516	9604	1.13855341738553
R-HSA-991365	Activation of GABAB receptors	 35	0.348170553356938	0.689762302653353	17	18	7518	9605	1.10602331974595
R-HSA-997269	Inhibition of adenylate cyclase pathway	 13	0.967997587249324	1	3	10	7532	9613	0.525486192639477
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	 22	0.0499123510164293	0.220163541862114	14	8	7521	9615	1.44906798576341
